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CHAPTER I
INTRODUCTION
The purpose of this dissertation is to characterize
the process by which extracellular proteins are degraded
by cultured macrophages.

The degradation of extracellu-

lar protein occurs within the lysosome.

It has been pro-

posed that the lysosome may also be the site of intracellular protein degradation under some conditions.

The study

of extracellular protein degradation may thus be a model
for some steps in intracellular protein turnover.

A study

of the degradation of extracellular proteins may therefore
contribute to an understanding of intracellular protein
turnover and may permit choices to be made between several
models proposed for the latter process.
I will begin this introduction by reviewing the current literature on intracellular protein degradation, as of
1981, and will present models that have been proposed to
explain this process.

I will then discuss the degradation

of extracellular proteins and how this process may be related to intracellular protein degradation.

1

2

A. Intracellular Protein Degradation
Intracellular protein degradation is believed to
serve several important functions in the cell.

It can

enable the cell to adapt to changes in its environment by
facilitating rapid changes in the concentrations of enzymes within the cell.

Thus, the more rapidly an enzyme

is degraded, the faster its intracellular concentration
can respond to changes in its environment (1, 2).

In

agreement is the observation in liver that enzymes which
catalyze either the first or the rate-limiting steps in
metabolic pathways have the shortest apparent half-lives
( 3) .

In nutritionally poor environments, protein degradation could enhance cell survival by providing a continued supply of amino acids for protein synthesis and/or to
serve as metabolic fuels for ATP formation.

During star-

vation, protein degradation has been found to increase in
bacteria (4-11), yeast (12, 13), and certain mammalian
cells in culture (14, 15).

During fasting by mammals,

amino acids derived from cellular proteins in muscle and
liver can be oxidized directly or their carbon skeletons
can be converted into glucose by the liver and kidney
(16).

Another function of protein turnover is probably the
removal of abnormal proteins within the cell that might

3

arise by mutations, errors in gene expression, denaturation, or chemical modification.

Mutant proteins, those

with a single amino acid substitution, were found to be
degraded at a faster rate than normal proteins in cultured mouse L-cells (17).

Abnormal proteins created by

growing cells in media containing amino acid analogs were
degraded more rapidly than normal proteins in bacteria
(18, 19), fibroblasts (20), and hepatoma cells (21, 22).
The degradative rates of different enzymes within
bacterial and animal cells can vary widely.

Heteroge-

neous rates have been found for membrane and organelle
proteins (1, 23) as well as soluble proteins (2).

In ad-

dition, these rates can vary under different physiological conditions.

In most cases, degradation appears to be

a first order process indicating that newly synthesized
protein is as likely to be degraded as old protein.
(2, 24, 25, 26).

This suggests that for each individual

protein, molecules are selected at random for degradation.
There appears to be a correlation between degradative rates and some physical properties of proteins.
In rat liver, soluble and membrane proteins composed
of larger molecular weight subunits turned over more
rapidly than those with smaller subunits (27-29).
This relationship did not hold for serum proteins (30).

4

However, in the latter case, the proteins must be cleared
from the circulation before degradation can occur so that
their turnover rate may be controlled by their rate of
uptake into tissues.

For both serum and tissue proteins

a correlation may exist between their isoelectric points
and half-lives (30-32), with the more acid proteins being
degraded more rapidly.

The relationships between degrada-

tion rate, subunit molecular weight, and isoelectric point
were also found in the mouse blastocyst (33).

A relation-

ship may also exist between the hydrophobicity of a protein and its rate of turnover (34, 35) with the more hydrophobic molecules being degraded at a faster rate.

It

was suggested that this could be due to an increased association of hydrophobic proteins with cellular membranes,
leading to a preferential uptake into lysosomes.
Conformation also appears to affect the rate of protein turnover.

Thus, it has been suggested that the in-

creased rates of degradation which have been observed for
mutant or modified proteins (18-22, 32) may be a consequence of their abnormal and possibly less stable conformations.

In bacterial mutants, incomplete chains of S-ga-

lactosidase which differ in conformation, as determined
by their ability to cross-react with antibody, ware degraded at different rates (36).

Although a small correlation

5
existed between chain length and half-life, a much
stronger correlation existed between conformation and
half-life.

Chains with conformations similar to that of

the native protein, as determined by antibody cross-reactivity, were degraded more slowly.

Additional evidence

for the importance of protein conformation on degradative
rates was shown by studies of the effects of bound ligands
on protein half-lives.

Tryptophan pyrrolase (37), serum

albumin (38), aspartate transcarbamylase (39), staphylococcal nuclease (40), and ribonuclease (41) were observed
to be degraded more slowly upon the binding of specific
ligands in vivo.

This effect was attributed to changes in

the conformation and/or stabilization of the conformation
of the proteins caused by ligand binding (42).

Similarly,

both hemoglobin and glycogen phosphorylase were shown to
be degraded more rapidly in vitro on the binding of oxygen
(43) and glucose (44) respectively.

Thus, the concentra-

tion of various ligands within the cell, such as substrates, cofactors, inorganic ions, etc., could regulate
the rate of degradation of individual proteins.
One study, however, appears to dispute the effect of
conformation on turnover rate (45).

Various tyrosine-ami-

no-transferases containing different amino acid analogs
were found to be less heat stable and only 2/3 as

6

catalytically active when compared to the native protein
but their turnover rates in rat liver were found to be
similar.
The mechanisms by which hormones and metabolites
regulate the rates of protein turnover have been investigated in cells in culture, in tissue slices, and in perfused organs. Isolated hepatocytes labeled with 3H-amino
acids degrade about 4.5% of their cellular protein per
hour (46).

This degradation was decreased by inhibitors

of ATP formation and by the addition of insulin and several aminG acids to the medium or perfusate.
The control of protein turnover by insulin, however,
may be an involved process since it has been found to increase protein s;mthesis as well as decrease degradation
in tissues (47, 48) and in cultured fibroblasts (49).
Insulin appears to antagonize the adenyl cyclase system,
as do oxytocin and prostaglandins, while hormones such as
epinephrine, glucagon, ACTH, TSH, LH, secretin, and GH
stimulate it (50-57).

As will be explained later, cAMP

appears to be involved in endocytosis and, in the thyroid,
TSH has been found to increase endocytosis (58).

In con-

trast to insulin, glucagon appears to stimulate protein
degradation in the liver (59) .

This effect annears to be
.t

.1.
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secondary to a glucagon induced depletion in the cellular
levels of several free amino acids, notably glutamate
( 60).

Intracellular protein degradation also appears to be
regulated by the availability of ATP.

Murakami, et al.,

(61) looked at the degradation of proteins with abnormal
conformations using cell-free extracts from E. Coli and
found it to be an energy dependent process.

Incomplete

fragments of S-galactosidase generated through nremature
termination of protein synthesis were degraded in this
system by a process that depended on a continued availability of ATP. Cell free extracts from E. Coli also
degraded 14 c-methylapohemoglobin in an ATP dependent fashion.

Other nucleotide triphosphates and ADP were less

stimulatory than ATP while AMP, NAD, NADH, guanosine
tetraphosphate and a., B, and y-methylene ATP did not afford significant stimulation.

The requirement for ATP

could not be explained by a requirement for protein synthesis as the stimulation by ATP was not affected by chloramphenicol (62).

The pH optimum for this ATP dependent

proteolytic activity was 8.0.

The authors indicated the

need for further studies to explain this ATP requirement.
Kowit and Goldberg (63) , in studying the degradation

8

of a specific mutant S-galactosidase (X-90)

in~·

Coli,

were able to demonstrate that high energy phosphate was
required both for the initial proteolytic cleavage as
well as for the subsequent hydrolysis of the degradative
intermediates.
Extracts of E. Coli were purified and this ATP
stimulating protease was found to have a molecular weight
of 115,000.

Reticulocytes also appear to have an ATP

dependent protease activity and it appears to be a distinct cellular enzyme of non-lysosomal origins (62).

It

has an optimal pH of 7.8 and remains in the supernatant
even after centrifugation at lOO,OOOg for several hours.
In contrast, fractions of cell homogenates enriched in
lysosomes had little proteolytic activity at pH 7.8 and
showed no stimulation by ATP.

The ATP dependent proteo-

lytic activity was not sensitive to the protease inhibitors pepstatin, leupeptin, or chymostatin which will
inhibit the lysosomal cysteine proteases.
ATP could stimulate protein degradation by participating directly in the catalytic process.

This could in-

volve an ATP dependent transformation of the substrate,
thereby increasing its susceptibility to proteolysis.
Alternatively, ATP could act to modify the protease

9

directly by inducing a change in protein conformation, by
participating in the reversible chemical modification of
the protease, or by participating in the inactivation of
an endogenous inhibitor.
In order to determine the chemical basis of the ATP
requirement in intracellular protein turnover, Hershko
and his associates have recently partially purified and
characterized an ATP dependent proteinase system from
rabbit reticulocytes (64).

They found this system to be

composed of several components.

One component is a

heat-stable polypeptide (APF-1) which has subsequently
been identified as ubiquitin (65), a protein discovered
earlier in many tissues but whose function was not known.
During protein degradation, this polypeptide appears to
become covalently linked to the protein substrate in an
ATP dependent fashion forming a high molecular weight
conjugate.

This conjugation reaction is inhibited by

N-ethylmaleimide.
ATP in this system.

UTP and GTP could not substitute for
These properties of conjugate for-

mation are similar to those of overall ATP dependent
protein breakdown in the same system suggesting that the
formation of a substrate-ubiquitin conjugate could be
obligatory intermediates in the degradative process,

A

10

mechanism for this process was proposed (66) .

The scheme

is as follows:
PROTEIN

~--------------

(APF)n-PROTEIN

+

,[

nATP
nAPF

f----_____

--------

nAPF-X & AMINO ACIDS

Conjugation involves an enzymically catalyzed synthesis of
a covalent bond between APF-1 and the E-NH 2 group of
lysine in polypeptides and proteins. The portion of the
APF-1 molecule that is involved in conjugation appears to
be the COOH-terminal glycine (153).

This enzymic activ-

ity, "APF-1-protein amide synthetase," is either precessive or has a high preference for protein previously conjugated with APF-1, as derivatives with more than one
APF-1 molecule will appear under conditions of excess free
substrate protein. ATP is specifically required for this
reaction.

A reverse reaction, the generation of APF-1

from APF-1 protein, is catalyzed by an amidase.
amidase does not require ATP.

The

(66).

(APF) n -Protein is cleaved by peptidases that act on
(APF-l)n derivatives to yield nAPF-X where X is lysine or
a 3mall peptide.
( 66) .

The Apf-1 is regenerated by an amidase
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It remains to be demonstrated whether such a system operates in eukaryotic cells other than reticulocytes.
In addition, studies of the purified ATP dependent proteolytic system from E. Coli suggests that it may be very
different from the rabbit reticulocyte system (154, 155).
Poole and Wibo (67) studied protein turnover in
rat fibroblasts in culture and found that many cellular
proteins could be divided into two categories; those with
short half-lives (approximately 1-10 hours) and those with
long half-lives.

They observed that fluoride, iodo-

acetate, and chloroquine affected the rates of degradation
of both types of proteins to similar extents (68).

These

compounds all inhibit proteolysis within the lysosome.
In contrast, variations in the composition of the culture
medium affected the degradation of proteins with long
half-lives only.

Their degradation was inhibited by in-

creasing levels of serum in the culture media and enhanced by conditioned media.

Addition of amino acids

to the medium also inhibited the degradation of the proteins with long half-lives.
The requirement for ATP for the degradation of the
two classes of proteins is not clear.

Fluoride and iodo-

acetate decrease cellular ATP levels but the inhibition
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of protein degradation observed did not parallel their
effects on the cellular ATP levels.

In general, these

results could be interpreted to indicate that different
pathways exist for the degradation of proteins with slow
and fast turnover rates but that these pathways might
share one or more steps in common (68).

It was further

suggested that the degradation of the more stable proteins involves a step not necessary for the degradation
of more labile proteins.

In another study (69), it was

found that media deficient in serum, amino acids, phosphate, or glucose caused a twofold increase in the rate
of degradation of long-lived cellular protein but had no
effect on the rate of degradation of proteins with short
half-lives.

Insulin, dexamethasone, and fibroblast

growth factor acted synergistically to inhibit the enhanced protein degradation caused by serum deprivation
and to stimulate thymidine incorporation to levels similar to that seen with complete media containing serum.
The enhanced proteolysis caused by serum-deficient media
(long-lived protein) was found to be inhibited by
vinblastine, a microtubule inhibitor, but vinblastine
had no effect on basal proteolysis (70).

Therefore, only

enhanced proteolysis seemed to involve microtubules.
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R. B. Hendil (71) found that the rates of degradation of
protein with long and short half-lives were increased in
fibroblasts maintained at a high cell density.

In con-

trast, protein degradation in SV 40 transformed cells
was affected by serum deprivation but had lost its response to high cell density.
The participation of the lysosomes in the degradation of long and short-lived proteins in isolated rat
hepatocytes was investigated using reagents that inhibit
the lysosomal digestion of protein (72) .

Ammonia inhib-

ited by 70% the degradation of long half-life proteins
but only inhibited the degradation of short half-life
proteins by 45%.

The results for chloroquine and meth-

ylamine, both of which are lysosomotropic reagents that
concentrate in the lysosomes, were the same as those for
ammonia.

In addition, the inhibitions produced by these

reagents were not additive.

On this basis, it was con-

cluded that there may be more than one pathway for the
degradation of cellular proteins and these pathways may
make different contributions to the degradation of long
and short-lived proteins.
In a second study, leupeptin, an inhibitor of lysosomal cysteine proteinases, was also found to be unable
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to completely inhibit protein turnover.

In addition, the

inhibition it produced was not additive with that produced by ammonia.

From these results it was hypothesized

that a non-lysosomal pathway may also contribute to cellular protein turnover.

In addition, it was hypothesized

that short-lived proteins were degraded mainly by a
non-lysosomal pathway since the lysosomal protease inhibitors did not significantly affect the degradation of
most of these proteins.

The majority of the stable pro-

teins appeared to be degraded by a lysosomal pathway as
lysosomal protease inhibitors decreased their rate of
breakdown by

70~~

(72) .

Neff et al. (73) also studied the degradation of
long and short-lived proteins in rat hepatocytes.

They

found that the protease inhibitors leupeptin, chymostatin,
and antipain inhibited the degradation of long-lived proteins by 20-30%.

A similar inhibition of degradation of
12 5

the extracellular protein
observed.

I-asialofetiun was also

In contrast, leupeptin, chymostatin, and anti-

pain did not significantly inhibit the degradation of proteins with short half-lives or abnormal proteins containing an amino acid analog.

These results are also con-

sistent with the existence of multiple pathways of
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cellular protein breakdown which make different contributions to the degradation of proteins with long and short
half-lives.
In summary, these studies suggest that normal cellular proteins fall into at least two populations: those
which turn over slowly and those which turn over rapidly.
It also appears that the pathways for their degradation
may be different, although they may share one or more
steps in common.

Long-lived proteins may be degraded in

lysosomes, as are extracellular proteins, while shortlived proteins may undergo initial degradation in the
cytosol.

The pathway for the degradation of short-lived

proteins may resemble that of abnormal proteins which
could arise from errors in translation, premature chain
termination, or incorporation of an amino acid analog
since abnormal proteins are also rapidly degraded (74).
Normal proteins which turn over rapidly may be enzymes
which play a regulatory role in metabolism (75).
The mechanism. by vJhich abnormal proteins are degraded has been investigated in

~·

malian cells (17, 18, 20-22).

Coli and in cultured mamWith E. Coli, abnormal

proteins were degraded more rapidly than normal proteins
by a process which is energy dependent.

In addition,
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while the degradation rates for normal proteins differed
in growing and non-growing cells, the rates of degradation of abnormal proteins were similar under both conditions.

The abnormal proteins were caused by errors in

translation, by growth in the presence of amino acid
analogs, and by puromycin which causes premature release
of nascent proteins from the ribosome.

Similar phenom-

ena were also obtained in mammalian cells in culture
(17, 18, 20-22).

In addition, aging in cultured fibro-

blasts, which has been hypothesized to cause an increased
accumulation of abnormal proteins, also causes an increased rate of proteolysis of cellular proteins (20).
Although some facts are known about intracellular
protein degradation and the effects of various factors
on its rate, the exact cellular mechanism is in doubt.
Where does the degradation take Dlace?

Studies with

reticulocytes and prokary9tes suggest, that degradation.
might occur outside the lysosome (32, 76).

Prokaryotes,

which are capable of degrading intrq.cellular proteins,
lack lysosomes.

The protease activity of reticulocytes

against abnormal globin was found to be due to a soluble
extra lysosomal system stimulated by ATP and having a
basic pH optimum.
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There is, however, strong evidence for the involvement of lysosomes in eukaryotic intracellular protein
turnover.

Liver perfusion studies showed the inhibition

of protein degradation by pepstatin, a specific inhibitor of cathepsin D (77).

This result is supported by

additional perfusion studies which demonstrated that
conditions which affect lysosomal proteolysis also affect
cellular protein turnover in a similar manner.

(78, 79).

In addition, lysosomes isolated from liver perfused under
conditions of increased protein turnover show differences
in their densities and fragilities from those isolated
under conditions of basal turnover (156).

Measurements

of the size of the lysosomal pool and volume of the
lysosomal compartment in the perfused liver indicate
that these increase under conditions of enhanced cellular protein degradation (157, 158).

Calculations of

the rate of lysosomal protein degradation, based on the
size of the lysosomal substrate pool under various conditions, has been cited as evidence for the sole participation of lysosomes in cellular orotein turnover.

In

vitro studies also suggest the involvement of lysosomal
enzymes in intracellular protein degradation since the

relative rates of degradation of various proteins by
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lysosomal enzymes in vitro were similar to their relative
in vivo degradation rates.

In vivo studies with lysosomal

protease inhibitors (46, 85-87) and agents that cause
lysosomal dysfunction, such as chloroquine, (46, 85,
88-90) also support the involvement of lysosomes in protein degradation in the cell.
The importance of lysosomes in protein degradation,
in the diseased state, was shown by the delayed degeneration of dystrophic muscle in cell cultures in the
presence of pepstatin, leupeptin, and antipain (91) and
in vivo in the presence of pepstatin and leupeptin (92).
However, in all cases, lysosomal protease inhibitors and
lysosomotropic reagents, eithe= singly or in combination,
are incapable of completely abolishing intracellular
protein degradation.

This perhaps implies the contribu-

tion of an extralysosomal pathway.
If eukaryotic protein degradation occurs in the
lysosome, how are proteins transported into the lysosome
from other cellular compartments?

One possibility in-

volves a kind of internal phagocytosis which has been
called autophagy.

The ATP reauirement of ?rotein turnover

may thus be due to an energy dependence for autophagy.
One

~roblem

with this hypothesis is that it has difficulty
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accounting for the observation that the rates of turnover
of proteins are quite variable.

Even many of the proteins

of a given cellular organelle show varied turnover rates
indicating that the organelle is not degraded as a unit.
To accommodate these observations, it has been proposed
that proteins which can bind to the lysosomal membrance
may be internalized more rapidly and thus are more rapidly
degraded.

It has been shown that proteins with short

half-lives accumulate preferentially at water-organic
solve~t

interphases when aqueous liver homogenates are

incubated with an immiscible organic solvent (93) and tend
to associate preferentially with lysosomal pellets (94).
In agreement, proteins with more rapid turnover rates
appear superficially more hydrophobic and bind preferentially to hydrophobic chromatography resins (34, 35).
In addition, hormones that decrease protein degradation,
such as insulin, have been
is involved in endocytosis.

show~

to decrease cAMP, which

However, it has also been

reported that observation, which causes increased protein
turnover, largely abolishes the differences in the degradation rates of various cellular proteins.

Since

starvation induced proteolysis is believed to be
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autophagic and to involve lysosomes, this finding has
been interpreted to mean that basal protein turnover
occurs by a second pathway which is more sensitive to
the physical properties of the cellular protein substrate (94b).
An alternative model involving lysosomes has been
proposed to account for differences in the rate of degradation of cellular protein.

According to this model,

a protein's natural susceptibility to degradation by
lysosomal proteases may determine its biological halflife.

Many studies with lysosomal extracts and intact

cells offer some support for this hypothesis (87, 95-98).
It was found that the half-lives of proteins in vivo
correlated roughly with their rates of degradation in
vitro.

There was also found to be some correlation be-

tween the activity of lysosomal proteases and the rate
of intracellular protein degradation.

It was postulated

that the rate-limiting steps of protein turnover occur
in the lysosome and that differences in degradative rates
between various proteins reflect inherent differences
in their susceptibilities to lysosomal proteases.

One

problem with this hypothesis is that it requires that a
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protein which escapes digestion can exit the lysosome.
According to this hypothesis, proteins which are degraded
more slowly by lysosomal enzymes would have a greater
probability of escaping the organelle intact.

Segal et al.

(98) demonstrated that yeast invertase could escape intact
from the lysosomes and proposed a model for intracellular
protein degradation (Figure I).

Step number 3, the rate

of degradation to large peptides by lysosomal proteases,
is hypothesized to be rate limiting.
In this model, a protein can leave as well as enter
the lysosome intact (Step 2) .

The protein would then be

degraded to large peptides (Step 3).

Step 3, the rate of

degradation by lysosomal proteases, is hypothesized to be
rate limiting under some circumstances.

The protein can

also be altered in the cytoplasm (Step 1) to become susceptible to possible extra-lysosomal degradation (Step 2) .
The large peptides produced in Step 2 would then enter
the lysosome where they would be degraded further.

The

final product of degradation would be the amino acids
that are released from the lysosome.
Haider and Segal (99) demonstrated that substances
that affect in vivo turnover of proteins were also capable
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Figure 1.

Model for intracellular protein degradation.

Native protein can enter the lysosome directly (Step 2)
or after modification in the cytoplasm (Step 1) .

The

modified proteins either enter the lysosome or are
I

I

partially degraded (Steps 1, 2 , and 3 ) .

The intact

proteins in the lysosome are degraded to large peptides
(Step 3).

The large peptides are further degraded in

the lysosome.

The resulting amino acids are then re-

leased from the lysosomes.

The active, native protein

is able to escape degradation by exiting the lysosome
before (Step 3) has occurred.
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of modulating degradation of protein in isolated lysosomes as well and they formulated equations to explain
the rates they observed (Figure 2).

In their model,

there is non-differentiated engulfment followed by
enzymic inactivation.

In Figure 2, Co equals the con-

centration of protein, Ci equals its concentration
inside the lysosome, and k 1 is the rate constant describing the transport of the protein into the lysosome.
The

p~otein

can also escape the lysosome with a rate

constant of k 2 or it can be degraded by the lysosomal
proteases with a rate constant of k 3 . The specific
removal rate (ksp) of a protein from a cell is therefore dependent on the rates of these three processes
and is given by
ksp

=

kl

k3

k2 + k3
under steady state conditions.

When k3 >> k2, rate of

degradation much greater than rate of exit from the lysosomes, the specific removal rate will equal k 1 , the rate
of entry into the lysosome. Substances that affect k 3
will have only small effects on the turnover of protein.
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Figure 2.

Proposed equations describing intracellular

protein turnover.

Co represents the concentration of

a protein in the cytoplasm while Ci represents its concentration within the lysosome.

The rate constants k 1
and k 2 refer to the rate of entry and exit of the protein from the lysosome. The rate of intralysosomal
degradation of the protein is given as k 3 . The removal
of a protein from the cell is therefore described by
k sp, the specific removal rate, and is equal to k 1 k 3
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If k 2

>>

k 3 , ksp is approximately equal to (k 1 /k 2 ) k 3

and substances that affect k 2 and k 3 will now also
affect the turnover rate as well.
One result that supports the escape of peptides
from the lysosome is the finding that lysosomal extracts from liver are incapable of completely digesting
protein substrates (100).

Further degradation occurred

uoon the addition of the high

s~eed

supernatent at pH 8.

It was postulated that small peptides were transported
or diffused across the lysosomal membrane to be further
degraded in the cytoplasm.

However, in experiments with

isolated lysosomes (101) and lysates from macrophages
(102), it was found that there was a limit to the molecular size of solute molecules which can cross the lysosomal membrane.

Polypeptides would not be able to escape.

Only small molecules could cross the lysosomal membrane.
Thus, it appears that the results of Segal et al.
(98) which demonstrated the transfer of invertase from
the lysosome to the cytosol may represent an exception.
At present, there is no evidence for an appreciable
transfer of intact proteins from the lysosome to the
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cytosol as a generalized phenomenon.
It has also been argued that protein denaturation
may be the rate determining step in protein turnover
(103).

On incubating proteins with lysosomal extracts

in vitro, it was found that denaturation was required
for extensive digestion of this mixture by lysosomal
hydrolases.

The rate of denaturation of a protein in

vivo may therefore determine its rate of degradation.
Although this can account for variable turnover rates
for proteins, it does not expiain how denatured proteins might be preferentially taken up into lysosomes.
However, it is possible that denaturation could expose
the hydrophobic regions of a protein which could interact with the lysosomal membrane causing increased uptake
into the lysosomes.
The model proposed in Figure I proposes that while
early steps in protein degradation may occur in the cytosol, the latter stages occur primarily in the lysosome.
In contradiction, some evidence exists for an independent
non-lysosomal pathway for protein degradation.

This

includes: the finding that lysosomal protease inhibitors
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can not completely block protein degradation; the observations that there exists two classes of proteins whose
degradation rates are differentially affected by hormones
and which show differential susceptibilities to the action
of lysosomal protease inhibitors; the finding that inhibitors of ATP formation block basal protein turnover but
not the augmented protein turnover observed in nutritionally deprived cells; the observation that starvation abolishes differences in the degradation rate of cellular protein; and the discovery of a non-lysosomal proteolytic
activity in the extracts of reticuloyctes and possibly
liver.
A model for the degradation of cellular protein by
a dual pathway has recently been proposed by Knowles and
Ballard (22) .

In studies of the degradation of normal

proteins and aberrant proteins containing an amino acid
analog, 1-canavanine, in hepatoma cells, some evidence
was obtained for the model shown in Figure 3.

It was

found that normal proteins were degraded more rapidly
than native proteins.

Furthermore, in contrast with

normal proteins the degradation of abnormal proteins
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Figure 3.

Dual pathway model for intracellular protein

degradation.

The active pathway (Pathway A) involves

nrotein uptake into and degradation by lysosomes.

This

pathway degrades short and long lived proteins at similar relative rates which are determined by the rate of
autophagy.

The inactive pathway (Pathway B) would de-

grade various cellular proteins at different rates which
would depend on their rates of denaturation and thus on
their inherant stabilities.
This stability could be modulated by ligands.

The

first and rate determining step in this pathway, B1 , involves denaturation of the protein. The denatured protein is then degraded in Step B2 . Pathway B is suggested
to be extralysosomal. The active pathway, pathway A, becomes activated on nutritional step-down as a consequence
of increased autophagy.
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was not inhibited by lysosomal protease inhibitors, fetal
calf serum, insulin,

or cyclohexamide.

To account for

these observations, it was proposed that all proteins
could be degraded by an active pathway involving autophagy
(Pathway A).

This pathway could be inhibited by lysosomal

protease inhibitors and lysosomotropic reagents.
It was proposed that the lysosomal pathway degrades
the different classes of cellular proteins at similar
relative rates.

Therefore, to account for the observation

that various proteins are degraded at different rates, it
was proposed that a second pathway, termed the inactive
pathway, is also present.

This pathway, which was hypoth-

esized to degrade abnormal or inactive proteins by a
process which did not involve lysosomes, was presumed to
be regulated by the intrinsic stability of each protein.
Accordingly, protein breakdown is initiated by denaturation (Step B ). The rate of denaturation would reflect
1
the inherent stability of each protein molecule and would
vary, thereby accounting for differences in degradation
rates between proteins.

In addition, the stability of

various proteins could be modulated by ligands.

According
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to this hypothesis, short-lived proteins are those which
are rapidly denatured or inactivated in vivo.

Step B2

depicts the degradation of denatured proteins to free
amino acids.

It is suggested that the inactive pathway,

Pathway B, does not involve lysosomes because the rates
of degradation of short-lived molecules are not significantly affected by the lysosomal protease inhibitors.
This proposal is attractive because it provides a
means by which the cell may remove abnormal proteins which
is free from the regulatory constraints associated with
the physiological degradation of normal proteins.
In summary, the process of intracellular protein
degradation is not completely understood; there is disagreement as to exactly where in the cell degradation
occurs, whether one or more pathways participate, and on
the nature of the steps involved.
may occur in lysosomes.

At least some steps

However, mechanisms in which the

lysosome is the exclusive site of cellular protein degradation now seem untenable.
Essential components of any explanation of protein

degradation must account for differences in the turnover

34

rates for various cellular proteins.

It has been sug-

gested that the rate of turnover of an individual protein
is determined by its intrinsic sensitivity toward endogenous proteases (80-84).

However, why different proteins

show different susceptibilities toward digestion is unknown.

In addition, the sequence of events in protein

degradation within the lysosome is also only poorly described.

Information about lysosomal protein degradation

may be obtained by studying the degradation of extracellular proteins since these appear to be taken up and degraded exclusively within these organelle.

This approach

also permits one to determine possible correlations between known structural features of proteins and their intrinsic sensitivity toward digestion in lysosomes and to
study a process which may be a model for one or more
steps in intracellular protein turnover.
B.

Extracellular Protein Degradation
Extracellular proteins are taken up by cells in cul-

ture by endocytosis.

Ehrenreich and Cohn (104) demon1 2 5

strated that the conditions for uptake of

I-HSA by

macrophages correlated well with the conditions favorable
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for pinocytosis; fetal calf serum (50%) and dextran sulfate enhanced uptake while parafluorophenylalanine, which
inhibits pinosome formation, had an inhibitory effect.
Uptake of non-digestible material as well as denatured
albumin by macrophages demonstrated that uptake was linear
with time for 7 hours (105).

Similar results were also

obtained with sarcoma cells (106).

Experiments utilizing

rat yolk-sac showed that extracellular protein enters in
the liquid phase.

Denaturation of the protein increased

its uptake by permitting its binding to cell surface components (107), a result that was also duplicated in other
experiments with yolk sacs (108).

It was suggested that

the digestive capacity of the lysosomes exceeded the caDacity of cells to take up proteins, and therefore, pinocytosis was the rate determining step in the processing of
exogenous proteins.
Factors influencing the rate of uptake of extracellular protein, other than protein structure, were also investigated.

Inhibitors of glycolysis and respiration re-

duced pinocytosis in macrophages.

Protein synthesis is

also required for pinocytosis since it was inhibited by
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puromycin and P-fluorophenylalanine (109).

A reduction

in pinocytosis was also found as the temperature was
lowered.

Pinocytosis is stimulated by high concentra-

tions of calf serum (110, 111) as well as by anionic molecules (112).

It is also stimulated by cAMP, ADP, and

ATP (113) .
and

Catecholamines and prostaglandins E1 PGA 1
,
'
which elevate ck~ levels, also stimulate pino-

Fz
'

cytosis (114).

A similar effect was also observed for

theophylline and papaverine, inhibitors of cyclic nucleophosphodiesterase.

Other hormones which affect cellular

cAMP levels (47-58) would therefore affect pinocytosis.
Endocytosis of digestible material causes an increase in the activity of the lysosomal enzymes.

This

appears to involve de novo protein synthesis since this
induction is inhibited by puromycin (115).

The induction

is also inhibited by colchicine (116) and stimulated by
chloroquine (117).

This induction of digestive enzymes

does not occur after endocytosis of non-digestible material (115).
After uptake, endocytosed material is localized
within the lysosome (118-122) where the endocytosed protein is then digested by lysosomal proteases.

In vitro
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experiments demonstrated the ability of lysosomal protease
to digest proteins.

Studies using lysosomal orotease in-

hibitors showed the importance of cathepsins B1 C, and D
'
for protein degradation (123) . The importance of cathepsin
D was also shown by studies utilizing an antiserum to the
enzyme that inhibited protein degradation in cultured
cells (124).
Degradation of extracellular proteins pre-loaded in
macrophages was found not to require ongoing pinocytosis,
oxidative phosphorylation, or protein synthesis but was
found to be temperature dependent (104).

In contrast, in

liver slices it was found that degradation of extracellular protein in lysosomes does require ATP, as inhibitors
of energy formation were also able to partially inhibit
protein degradation (125).

These liver slices were col-

lected 30 minutes after intravenous injection of Formal1 2 5

dehyde treated

I-BSA into mice.

studied for 60 minutes.

The degradation was

However, there was only 60% cell

viability after 60 minute incubation.

Studies with

isolated lysosomes (101) and cultured macrophages (102),
as discussed previously, suggested that digestion of
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protein within the lysosome is complete as small peptides
are too large to escape from the lysosome.

Proof of this

comes from the analysis, by paper and column chromatography, of the products released when cultured cells
(104, 126-128) and isolated phagosomes, vesicles that appear as the result of phagocytosis (129), degraded exoge12 5

nous

I-labeled protein.

In each case, the only labeled
1 2 5

oroducts released into the medium are free

I, mono-

iodotyrosine, diodotyrosine, and glycyliodotyrosine; no
intermediate molecular weight products were observed.
In the isolated phagosomes, the degradation was inhibited
by sucrose and salts which is similar to the effect that
these two substances have on the degradation of pinocytosed proteins in vivo.
It has frequently been observed that a significant
quantity of material endocytosed by cultured cells may
subsequently be released into the media.

Approximately

12 8

20% of the total colloidal

Au-gold taken up by macro-

phages is released into the media within the first hour,
and thereafter, very little further release is seen in
subsequent hours (105).

A similar result was obtained for
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125

I-PVP. The cells therefore appear to regurgitate some

undigested material in an initial period following uptake.
A qualitatively similar result has been obtained on feeding

1 9 2

Ir to macrophages.

However, in this case, 50% of

the label was released from the cells in the first day
following uptake but no more was released for the next 21
days (130).
Degradation of extracellular protein by cultured
cells has been examined by two methods.

Steinman and Cohn

(131) fed soluble horseradish peroxidase to mouse peritoneal macrophages and studied the loss of peroxidase activity from macrophages with time.

The half-life ob-

tained by this method was approximately 8 hours.

In con-

I 2 5

trast, when

I-labeled peroxidase was used, the half-life

based on the loss of radioactivity from the cells was 20
to 30 hours.

The discrepancy in rates could be due to the

larger number of peptide bond cleavages required before
the label can exit the cell compared with the number of
peptide bond cleavages required for inactivation.

Studies

1 2 5

utilizing

I-albumin (104, 126) found that the loss of
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label from the cells was biphasic, a fast phase followed
by a slower one.

The rate of loss was increased when the

concentration of serum in the media was raised.

After 24

hours, 75% of the labeled albumin originally present in
the cells was released.
12 5

To make sure that the release of

I activity into

the media was due to protein degradation, Ehrenreich and
125

Cohn (127) studied the degeneration of

I-Hb and

leucine- 3 H-Hb by macrophages and found the results to be
identical.

The degradation of Hb was found to be slower

than that of albumin as only 50% of the label was released
from the cells after 24 hours.

The isotope lost by the

cells could be accounted for as TCA - soluble isotope appearing in the medium.
C.

Purpose
The purpose of this study was two-fold.

First we

wanted to characterize the process by which extracellular
proteins, incorporated into macrophages by endocytosis,
are degraded.

This process takes place in lysosomes,

which are also possible sites of intracellular protein
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degradation.

In the model for intracellular degradation

illustrated in Figure 2, the degradation of long-lived
proteins is suggested to occur primarily in the lysosome.
In addition, it has been suggested that the rate of turnover of many intracellular proteins may be determined by
their rate of degradation in the lysosome.

Therefore, it

was hoped that studies of protein degradation following
pinocytosis might contribute to an eventual understanding
of the mechanism of intracellular protein turnover.

In

addition, it was felt that these studies could contribute
to an understanding of the structural features of proteins which control their rates of proteolytic degradation.

However, in order to carry out studies on the cel-

lular degradation of extracellular proteins, it was first
necessary to develop a methodology that required a minimum
amount of cells, media, and labeled protein substrates and
which yielded reliable and reproducible results.

CHAPTER II
EXPERIMENTAL
A.

Materials
1.

Substrates for Cellular Uptake and Degradation
Dextran, human serum albumin, cytochrome c,

phosphorylase b, hemoglobin, arginase, ribonuclease,
B-galactosidase, thyroglobulin, catalase, and enolase
were obtained from Sigma Chemical Company.

Ovalbumin

was a product of Nutritional Biochemical Corporation.
Dextran-sulfate (molecular weight 2 x 10 6 ) was from
12 5

Pharrnacia Fine Chemicals and

I-bovine serum albumin

was obtained from New England Nuclear.
2.

Labeling Reagents
Na

125

I,

14

C-glycine,

3

H-glycine and

14

C-acetic

anhydride were obtained from Amersham-Searle.

Cyanogen

bromide was purchased from Aldrich Chemical Company.
Chlorarnine-T and lactoperoxidase were products of Sigma
Chemical Company and the enzymobead kit for radioiodination was obtained from Bio-Rad
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Labor~tories.
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3.

Inhibitors
Antipain, leupeptin, and pepstatin were products of

the Protein Research Foundation.

Soybean trypsin inhibi-

tor (Kunitz) was from Worthington.

Chloroquine was ob-

tained from Sigma Chemical Company.
4.

Cell Culture Material
Lux polystyrene tissues culture petri dishes

(35 x 10 mm) and multiplates were obtained from
Microbiological Associates.

Media 199 (1 x, with Earles

salts, 2.2 g/1 sodium bicarbonate, and 1-glutamine),
Earles balanced salt solution, virus screened fetal calf
serum, penicillin-streptomycin sulfate, and 1-glutamine
were from Grand Island Biological Company.
Media was supplemented with fetal calf serum
(1-50%) penicillin (1,000 units /ml), streptomycin sulfate
(1,000

~g/ml),

and 1-glutamine

(2m~)

before use.

The

media used in the uptake of radioactively labeled substrates contained 50% fetal calf serum.

The media used in

measuring rates of degradation of pinocytosed proteins
contained varying amounts of fetal calf serum although
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experiments were most commonly performed with media containing 1% fetal calf serum.
in a Forma Scientifica
5%

co 2
5.

co 2

All cells were maintained

incubator in an atmosphere of

and at 37°C.
Gel Chromatography

Sephadex G-25, G-50, and G-75 were from Pharmacia
Fine Chemicals.

Affigel-Blue was obtained from Bio-Rad

Laboratories.
6.

Electrophoresis
Electrophoresis on agarose film was done with the

Corning cassette electrophoresis system.

For poly-

acrylamide disc gel electrophoresis, acrylamide,
methyl-bis-acrylamide, and TEMED were obtained from
Eastman Kodak Company and sodium doedecyl sulfate was a
product of Sigma Chemical Company.
7.

Miscellaneous
Eight-week-old male Swiss mice were obtained from

Scientific Small Company.

Fibroblasts, low passage baby

hamster kidney cells (BHK-21/Clone 13), were a gift from
Dr. Gene Majors.

Freund's complete adjuvant was obtained
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from Grand Island Biological Company.
(0.2~m)

were from Gelman and dialysis tubing was obtained

from Fisher Scientific Company.
fro~

B.

Acrodisc filters

Trypsin was obtained

Sigma Chemical Company.

Methods
1.

Synthesis of Labeled Substrates
a.

Labeled Dextrans

14

14

C-dextran and

C-dextran-sulfate were synthesized

by the method of Marshall and Rabinowitz (132).

Fifty

l 4

~Ci

of

C-glycine was incubated for 24 hours with 550 mg

CNBr-activated dextran, yielding a label product with a
specific activity of 50

cpm/~g.

Dextran-sulfate was
14

labeled in a similar manner by adding 250

~Ci

C-gly-

cine to 600 mg of the CNBr-activated dextran and stirring
14

in the cold for 23 hours.

The resultant

C-labeled

dextran-sulfate had a specific activity of 125
3

using

3

cpm/~g.

H-dextran was synthesized by the same procedure
H-glycine.

Two hundred and fifty

~Ci

of tritiated

glycine was added to 500 mg activated dextran and the
reaction was allowed to proceed for one week.

The result-

ant labeled dextran had a specific activity of 190 cpm/ug.
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In preparing the various labeled dextrans, cold
glycine was added at the end of each reaction to modify
any of the free CNBr-activated sites which had not previously reacted with the label.

The solutions were then

dialyzed against distilled water in the cold to remove
any unbound label.

The samples were then lyophilized and

refrigerated.
Occasionally, the extent of labeling was monitored
.
during the course of the reaction by chromatographing
samples of the reaction mixture on a column of Sephadex
G-75.

The extent of the reaction could be determined

from the amount of label which co-chromatographed with
the high molecular weight dextran.
b.

Iodination of Proteins

Proteins were iodinated by three different techniques.

Hemoglobin and ovalbumin were iodinated by the

method of Hunter and Greenwood (133) using chloramine-!
1 2 5

and Na

I.

The labeled proteins obtained had specific

activities of less than 0.1 wCi/wg after purification on
a Seuhadex G-75 column.
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Human serum albumin was iodinated with lactopheroxidase by the method of J. Marchalonis (134) and purified by chromatography on G-75.
ity of 1.3

It had a specific activ-

~Ci/~g.

All of the proteins, with the exception of HSA,
were also labeled utilizing the Bio-Rad enzymobead kit.
The reaction was stopped by filtering the reaction mixture through an acrodisc to remove the bead-bound enzyme.
12 5

Unreacted

I was subsequently removed by dialysis.

specific activities obtained varied from 0.1 to
depending on the urotein.

The

2l.~Ci/~g

Ovalbumin and hemoglobin la-

beled by this and the chloramine-T method gave similar results in all exneriments.
The labeled proteins were refrigerated after purification and generally used within 3 days.
also frozen for later experiments.

Some were

Media was added to the

labeled protein solution just before use.

The radio-activ-

ity of protein samples stored for any period of time was
1 2 5

corrected for the known decay rate of

I.
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2,

Collection of Macrophages
Eight-to-twelve-week-old male mice were injected

intraperitoneally with 0.75 ml 4% thioglycollate media
through a sterile filter to elicit stimulated macrophages.

The cells were collected three days later by

flushing the peritoneum with sterile Earls balanced salt
solution through a syringe and collecting the lavage
solution in a second syringe.
was repeated twice.

Flushing of the peritoneum

The washings were combined in sterile

centrifuge tubes and the cells collected by low speed
centrifugation.

The salt solution was then aspirated off

and the cells resuspended in media.

The pooled cells col-

lected from 3 to 8 mice were counted in a hemocytometer
and aliquots containing 4 - 9 x 10 6 cells were plated on
glass slides or plastic petri dishes.

These numbers of

cells were found to pinocytose sufficient labeled material
to yield significant radioactivity when the cells were
counted.

Cell preparations were examined by phase con-

trast microscopy during initial studies and routinely with
a cell culture microscooe.
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1 4

Studies with

14

C-dextran and

were performed on glass coverslips.
found that

1 2 5

C-dextran-sulfate
However, it was

I-proteins incubated with glass coverslips

adhered to the glass giving rise to high background
counts.

Plastic plates were used to minimize this non-

specific binding.

Since fetal calf serum was found to

compete with labeled proteins for the non-specific binding sites on the surface of the plastic plates, the uptake media routinely contained 50% fetal calf serum.
This level of fetal calf serum was also found to stimulate pinocytosis (110, 111).
After the cells were dispersed onto glass coverslips or plastic tissue culture dishes, they were incubated at 37°C for one to three hours.

During this time,

the macrophages adhered to the surface of the plates.
The plates were then washed with sterile saline to remove
any non-adherent cells and fresh media added.

Cells used

for an overnight labeling experiment were then exposed to
media containing the labeled material for 12 to 20 hours
at 37°C in 5% co 2 .

Alternatively, in some experiments
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unlabeled media was added at this point and the cells subsequently treated with label the next day.
In some experiments, activated macrophages were
elicited by injecting 0.5 ml Freund's complete adjuvant
instead of thioglycollate media into the peritoneal cavity.
The cells were collected and treated in the same manner as
described for stimulated macrophages (those elicited by
thioglycollate media) .
3.

Uptake of Labeled Material by Cells
Media containing the radioactively labeled material

was added to the cell cultures and uptake of the label
was allowed to proceed for various oeriods of time.

All

cell cultures used in a given experiment were plated at
the same time and with the same known number of macrophages.

Fibroblast cultures were confluent monolayers

when used.

At the end of the uptake period, the labeled

media was removed by aspiration and the cells washed five
times with sterile saline.

They were then incubated in

media for 20 minutes and washed once more with saline.
This orocedure was adopted to insure removal of any nonspecific label adsorbed to the surface of the olates.
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The efficacy of this procedure was tested with blank
plates (plates without cells).
Cells cultured on coverslips were placed directly
into test tubes or scintillation vials for counting.
Cells cultured on plates were collected by sonifying
them in 1 ml distilled water for 10 minutes to disrupt
the cells.
tubes.

The disrupted cells were transferred to test

The plates were then washed with an additional

0.5 ml water and the washings added to the disrupted
cells.

The combined 1.5 mls obtained were then counted.

examination of the plates with a tissue culture microscope verified that no cells were left on the plate.
This method was found to maximize the collection of cellassociated radio-activity while minimizing the release of
any labeled protein that might be bound non-specifically to
the plate.

This was confirmed by comparing various col-

lection procedures with both blank culture dishes and culture dishes containing cells.
Blank plates or slides, those without cells. 'tvere
run concurrently with those containing cells in order to
determine what percentage of the label adsorbed to the
surface of the support.

Background counts, those from
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non-specifically bound label as well as noise from the
counting instruments, were substracted from the data.
In most experiments, the blank represented less than 5%
of the label collected.
4.

Degradation and Release of Pinocytosed
Labeled Material by Cells
The cell cultures were treated as described for the

uptake experiments except that the cells were not collected after washing.

Instead, fresh unlabeled media contain-

ing varying amounts of fetal calf serum was added to each
plate and the rate of release of radioactivity into the
fresh media was measured.
at various times.

Aliquots of media were removed

These aliquots were then treated with

an equal volume of 20% trichloroacetic acid - 1% phosphotungstic acid and the mixture incubated in an ice water
bath for 30 minutes.
by centrifugation.

The precipitated protein was removed
Both the supernatant and precipitate

were collected and counted in a gamma counter.

Media ali-

quots from experiments with the labeled dextrans were
placed directly into scintillation vials without precipitation.

Rates of protein release were also measured in a
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second way.

In these experiments, all the media was

removed at each time point and replaced with fresh
media, or only a small aliquot was removed and replaced with an equal volume of fresh media.

This was

done in order to determine if nutrient depletion from
the media or accumulation of metabolic end products in
the media might have affected the degradation and release of labeled protein.

These experiments also pro-

vide some information about whether any of the TCA-soluble radioactivity formed could have been due to the
degradation of intact labeled protein in the media by any
extracellular proteases which might be present or released by the cells.

The possibility of extracellular

proteolysis was also checked by examining the effects of
conditioned media on the labeled substrates.

In these

experiments, no evidence was obtained that the appearance of TCA-soluble radioactivity could be due to the
action of extracellular proteases on intact proteins
which might have been regurgitated from the cell or adsorbed to the surface of the culture dish.
At the end of the release experiment, the cells
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were collected in the manner described for the uptake
experiments and counted.
This method was developed so that all the data
points from one experiment came from a single plate followed over time and therefore the need to normalize the
data from different plates is obviated.

This is impor-

tant since estimates of cell density based on protein content are not sufficiently accurate when dealing with small
numbers of cells, can occasionally lead to anomalously
high values due to contamination of cells with even low
levels of serum proteins normally present in the culture
media, and can vary with cellular activity.

One problem

with this approach, however, is that the cell density in a
given plate may change with time as a consequence of cell
detachment and/or cell death.

It was found that the amount

of labeled protein collected from one plate before release
agreed within the variability observed in duplicate uptake
experiments

(~

15%) with the total amount of label associ-

ated with the cells undergoing release.

In the cells

undergoing release, the total amount of label is expressed
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as the sum of the TCA-soluble radioactivity released, the
TCA-insoluble radioactivity released, and the radioactivity remaining in the cell at the end of the release experiment.

Blanks, plates without cells, were also run in an

identical manner.
5.

Analysis of Released Label
Labeled material released into the media by cells

was analyzed by gel chromatography utilizing Sephadex
G-25 or G-50.

The gels were poured into a column and

equilibrated with at least three column volumes of buffer
before use.
The Sephadex G-25 column (1.6 x 10.5 em) was eluted
with water:phenol:acetic acid (1:1:1) at 20 ml/hr.

A 0.7

ml sample of TCA-soluble label was applied to the column
and 16 drop fractions collected to be counted in a gamma
1 2 5

counter.

Monoiodotyrosine (MIT) and Na

run on the column in an identical manner.

I were also
The MIT was

detected in the fractions by the ninhydrin method of
Moore & Stein (136).
Media samples, as well as TCA-soluble material,
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were chromatographed on a 1.6 x 60 em Sephadex G-50
column with O.OSM phosphate buffer, pH 7.3, containing
0.15 M NaCl at 30 ml/hour.

The sample size for this

column was 1.5 ml and 32 drop fractions were collected
and counted.
Uptake media, release media, and sonified cell
samples were also analyzed by SDS gel electrophoresis
according to the procedure of Weber and Osborn (137) .
Samples were run for 23 hours on an 18% crosslinked acrylamide gel.
each section counted.

The gels were then sliced and
All samples contained bromphenol

blue as a marker and the media samples also had phenol
red.

The solutions used in preparing the gels were as

follows:
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Gel Buffer: 0.2 M Phosphate, pH 7.2
0.2% SDS
Sample Buffer: 0.01 M Phosphate, pH 7.2
1% SDS
1% 2-Mercaptoethanol
Acrylamide B: 22.2 g Acrylamide/75 ml
0.6 g Methyl Bisacrylamide
Ammonium Persulfate: 15 mg/ml
Running Gel:

15 ml Acrylamide B
7.5 ml Gel Buffer
1.0 ml Ammonium Persulfate
0.045 ml TEMED

Reservoir Buffer:

1 part Gel Buffer to 1 part
distilled water

The tubes were run at room temperature at a
constant voltage of 4 mA/tube
6.

Miscellaneous
a.

Analvsis of Proteins Used

The proteins used for iodination were analyzed using
the Corning cassette electrophoresis system with agarose
film.

The buffer was 0.05 M sodium barbital, pH 8.6, with

0.035% EDTA.

Samples, 0.002 ml of a 4 mg/ml solution. were
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run for 40 minutes and the film stained for 20 minutes
in an amido black solution followed by washing with
acetic acid: methanol: water (1:7:2).

The film was

optically scanned in a Gelman scanner.
The proteins were also analyzed by SDS disc gel
electrophoresis utilizing the method of Weber and Osborn
(137) as described previously, except that the samples
were run on 7% gels.

After electrophoresis, the proteins

were fixed with acetic acid, stained with amido black,
and washed with acetic acid: methanol: water (1:7:2).
b.

Analysis of Labeled Material

Radioactively labeled dextran, dextran-sulfate,
and protein were analyzed by column chromatography.
After labeling,

14

C-Dextran was applied, in a 0.4 ml

sample in acetate buffer, to a 15 ml Sephadex G-75 column and fractions collected.

Aliquots of each fraction

were added to 10 ml Bray's solution and counted.

The

hexose content of each fraction was determined with
1 4

phenol-sulfuric acid (138).

C-Dextran-sulfate was

analyzed in a similar manner.
Iodinated hemoglobin was also analyzed by chromatography.

In this procedure, Sephadex G-75 equilibrated

in acetate buffer was used.

The fractions obtained were
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analyzed for both radioactivity and protein.

Twenty-

five percent of the label was found associated with
the protein peak.
1 2 5

The

I-BSA obtained commercially was subjected to

affinity chromatography on an Affi-gel blue Sepharose col1 2 5

urnn which specifically binds native albumin.

I-BSA

was added to the column in 0.02 M phosphate buffer, pH
7.1, and the column washed with this buffer until no more
1 2 5

radioactivity eluted.

The bound

I-BSA was then elu-

ted from the gel with phosphate buffer containing 1.4 M
1 2 5

NaCl.

Samples of affinity purified

I-BSA were then

dialyzed before use against water to remove salts.
Other proteins used in cellular uptake and degradation experiments were also analyzed by SDS gel electrophoresis on 7% gels essentially as described previously.
c.
1 2 5

Denaturation of Protein

I-BSA \vas denatured by immersing a solution con-

taining 0.2 mg/ml in a boiling water bath for 10 minutes.
Media was added after the solution cooled and this was
filtered before use.

The labeled heat-treated protein

remained soluble at these concentrations.

The denatur-

ation of the labeled BSA was verified by chromatography
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on an Affi-gel blue affinity column.
B-Galactosidase was denatured by freezing and thaw1 2 5

ing after labeling with

I.

The degree of denatur-

ation was tested by assaying for activity (139).
d.

Protein Degradation by Cell Lysates

Stimulated macrophages were plated and allowed to
incubate overnight before use.

Cell lysates were col-

lected from the plates by sanification for 10 minutes in
1 ml 0.1 M acetate buffer, pH 5.
Degradation of labeled protein by these cell
lysates was studied by two techniques.

In the first,

labeled protein was added to the cell lysate to give a
final concentration of 9 x 10 5 cpm/ml. In the second
method, 10

7

cpm/ml

125

I-protein was added to the cell

cultures for the overnight incubation and the cells allowed to pinocytose the label.

The cells were washed as

described previously and the lysates prepared.

For both

techniques, aliquots of the lysates were removed at various times, treated with an equal volume of 20% TCA-1%
phosphotungstic acid, and analyzed as described previously for TCA-soluble and TCA-insoluble radioactivity.
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e.

Partial Purification of Cathepsin B
1

Cathepsin B1 was partially purified from mouse
liver by the method of Bajkowski and Frankfater (140},
The liver was homogenized and stirred in 1% NaCl, 2%
N-butanol, 10-~ EDTA, 0.2% Triton X-100, pH 6.1, for
one hour and centrifuged to remove the precipitate.
The pH of the supernatant was adjusted to 4.4 with HAc
and spun again at 17,000 rpm.

The supernatent was mixed

with 1.3 volumes acetone and again centrifuged as before.
The precipitate was dissolved in 0.025M NaAc, pH5.1, with
0.1 M NaCl and 10- 3M EDTA and dialyzed overnight against
this same buffer.

The sample is then further purified by

chromatography on Sephadex G-150.
f.

Enzyme Assays
1.

Cathepsin B

Cathepsin B activity was assayed by the method of
Bajkowski and Frankfater (140) using CBZ-glycine-nitrophenyl ester as the substrate.

The enzyme is incubated

for 15 minutes with dithiothreotol in 0.025M NaAc, pH5.1
with 10- 3M EDTA before the addition of substrate.
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2.

Pauain

Papain was assayed by the same method as Cathepsin

B.
3.

Trypsin

Trypsin was assayed utilizing tosyl-argininemethyl ester (TAME) as a substrate (160).
used was O.SM Tris-HCl, pH 8.1.

The buffer

CHAPTER III
RESULTS
A.

Characterization of Labeled Substrates
Reaction mixtures containing CNBr activated dextran

or dextran-sulfate and radioactively labeled glycine were
analyzed by Sephadex G-25 chromatography at varying times
during the reaction to monitor the extent of the coupling.
Figure 4 shows the elution profile of the labeling solution of dextran-sulfate after 24 hours demonstrating that
14

C activity is associated with both high and low molec-

ular weight species.

Similar analysis of aliquots of the

labeling solution after 1, 2, and 13.5 hours demonstrated
1 4

a progressive increase in the percentage of

C activity

associated with the high molecular weight peak.

The per-

cent of label in the high molecular weight fraction increased from 15% after 1 hour to 27% and 85% after 2
hours and 13.5 hours respectively.

Similar results were
14

also obtained for labeling experiments with

C-glycine

3

or

H-glycine and dextran.

Proteins used in the prepa-

1 2 5

ration of

I-labeled substrates were analyzed prior to

labeling by electrophoresis with the Corning cassette
electrophoresis system to determine their purity.
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Most
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Figure 4.

Chromatography of the 14C-Dextran-sulfate

labeling solution on Sephadex G25 in 0.5M acetate
buffer, pH 5.0.

Aliquots (0.1 ml) of each 0.3 ml

fraction were added to 10 mls Bray's solution to be
counted in the scintillation counter.

The reaction

was allowed to proceed 24 hours before analysis.
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proteins yielded a single major band.

Ovalbumin and

catalase preparations appeared to contain minor impurities which represented no more than 20% of the total
protein.

Enolase showed two major bands whose propor-

tions varied with protein concentration and which probably represented a monomer-dimer equilibrium.

Similar

results were obtained for these proteins by SDS disc gel
electrophoresis.

Each lot of protein obtained was ana-

lyzed before use.
1 2 5

After labeling with
were further analyzed.

I, the protein substrates

Figure 5 is an elution profile

12 5

for

I labeled hemoglobin obtained with a Seuhadex

G-75 column (1.6 x 30 em).

It shows about 10% of the

radioactivity associated with the hemoglobin peak.

From

the areas under the peak and knowledge of the total protein, the specific activity of the labeled hemoglobin
could be estimated.
Other proteins, after labeling, were precipitated
with 10% TCA on ice and the amount of label associated
with the TCA-insoluble fraction was measured.

These

results were then used to estimate the specific activity
of these proteins.

The results summarized in Table 1

list the proteins labeled, the technique used, and the
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1 2 5

Figure 5.

Chromatography of the

I-hemoglobin

labeling solution on Sephadex G75 in 0.5 M acetate
buffer, pH 5.0.

Aliquots of each 1.8 ml fraction

were removed for counting.
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TABLE 1
LABELED PROTEINS USED

Protein

Labeling Technique

1JCih.1g

Arginase (Prep. 1)

Enzymobead

0.72

Arginase (Prep. 2)

Enzymobead

0.56

Catalase

Enzymobead

0.17

Cytochrome c (Prep. 1)

Enzymobead

1.17

Cyrochrome c (Prep. 2)

Enzymobead

1. 83

Enolase

Enzymobead

0.30

8-Galactosidase

Enzymobead

4.30

Hemoglobin

Enzymobead

1. 63

HSA (Prep. 1)

Lactoperoxidase

1. 30

HSA (Prep. 2)

Lactoperoxidase

0.73

Ovalbumin (Prep. 1)

Chloramine T

Ovalbumin (Prep. 2)

Enzymobead

0.43

b (Prep. 1)

Enzymobead

1.11

Phosphorylase b (Prep. 2)

Enzymobead

2.10

Ribonuclease (Prep. 1)

Enzymobead

1. 90

Ribonuclease (Prep. 2)

Enzymobead

0.04

Thyroglobulin

Enzymobead

1. 27

Phos~horylase

<0.001
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specific activities obtained.
12 5

I-BSA obtained commercially was characterized
by affinity chromatography on an Affi-gel blue column.
In this chromatographic support, Cibacron Blue F3GA, a
reactive blue dye, is covalently linked to an insoluble
agarose matrix.

The resulting gel will bind albumin and

other proteins which contain an organic anion binding
site.

With one batch of albumin, 3 separate determina-

tions yielded 81%, 79%, and 83% of the total radioactivity bound to the affinity column.

A similar analysis of
1 2 5

a second batch indicated 80% of the total
bound to the affinity column.

I activity

The bound fractions were

eluted as described previously.
B.

Uptake of Nondigestible Materials
The uptake of nondigestible material by cultured

macrophages was first investigated.
3

pinocytose

1 4

H- or

Cells were allowed to

14

C-dextran or

varying periods of time.
cell samples collected.

C-dextran-sulfate for

The cells were then washed and
In order to normalize the data

for differences in the amounts and

s~ecific

activities of

the labeled materials and differences in the quantities of
cells used in the various experiments, the results are
expressed as microliters of medium ingested per 10 6 cells
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plated (141) .
This value was calculated by the formula:
f.ll/10

6

Amount of Cell 'Concentration of
Associated
Radioactivitv in
Radioactivity/ Medium
·

Cells =

Number of Cells Plated/10 6
1 to

The uptake of

C-dextran-sulfate, which is known to

cause increased pinocytotic vesicle formation (142), is
shown in Figure 6.

Our data for the uptake of labeled

dextran is similar except that it occurs at only about
1/20 the rate of uptake of dextran-sulfate.
C.

Uptake of Digestible Substrates
12 5

7).

I-BSA uptake by cells was also studied (Figure

In this case, the accumulation was less than that

for nondigestible materials; possibly due to the ongoing
degradation of

12 5

I-BSA and release of free label into
1 2 5

the media.

The rate of accumulation of

I-BSA by the

cells was similar in the presence of dextran and markedly
increased in the presence of dextran-sulfate, which
causes increased pinocytotic vesicle formation (142).
The effect of different concentrations of labeled
BSA in the media on the amount taken up over a 12 hour
labeling period was also investigated (Table 2) .

These

experiments were performed with two different batches of
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14

Figure 6.

Untake of

macrophages.

C-dextran-sulfate by

Uptake was performed in 50% FCS with

5 mg/ml dextran-sulfate (160,000 cpm/ml) for
varying time periods.

Each time point represents
a separate plate with 3 x 10 6 rnacrophages.
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12 5

Figure 7.

Uptake of

I-BSA by macrophages.

Uptake
was performed in media with 50% FCS with 1 x 10 7
cpm/ml in the absence (*) and the presence of 1 mg/ml
dextran-sulfate ( o ) . Each point represents a single
plate with 2.6 x 10 6 cells.
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TABLE 2
125

I-BSA Uptake With Different Concentrations of
cpm/ml x 106
125

I-BSA

125

I-BSA in the Uptake Media

Cell Associated
Radioactivity
(cpm)

Macrophage
Preparation

]11/10 6 Cells
Platedb

1.7

lc

516,545

0.04

6.7

lc

2964,1924-

0.05

15.0

lc

5755,4851

0.04

4.0

2d

557,622

0.03

6.0

2d

783,948

0.03

12.0

2d

1419,1737 -

a

0.03

a

Uptake was performed in media with 50% FCS for 12 hours.
b

Average of 2 determinations
c
d

Number of cells plated was 7.9 x 10
Number of cells plated was 5.3 x 10

6
6

.......
0\

77
macrophages as indicated.

The rate of uptake was seen

to vary somewhat between the two preparations of cells.

In general, results of many such experiments show a
one to two fold variation in U?take rates between different batches of macrophages.

From the results in
12 5

Table 2, it can be seen that the cpm of

I-BSA accu-

mulated by the cells was dependent on the initial
cpm/ml in the media.

When the data is normalized for

the different cpm/ml media and cell numbers by expressing the results as ~ls of media ingested per 10 6 cells,
it can be seen that the amount of labeled media ingested
is relatively constant.

If the uptake were receptor

mediated, one would expect that the calculated volume of
media taken up per 10 6 cells would appear to decrease with
increasing concentration of labeled protein in the media.
Therefore, if receptors are involved in BSA uptake, they
could not have been saturated with BSA under these conditions.

This might be expected in view of the large quan-

tities of extraneous proteins present in the uptake media
arising from the presence of fetal calf serum (50}.

Con-

sistent with this finding is the observation that excess
cold BSA does not inhibit the uptake of labeled BSA
(Table 3).

These results also eliminate the possibility
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TABLE 3
125

I-BSA Uptake in the Presence of Varying Amounts of

Cold BSA a

Cold BSA Added
(mg/ml)

a

lll/10 6 Cellsb

0

15,420;16,542

0.023

0.1

12,314;17,686

0.021

1.0

11,699;19,888

0.023

Uptake was performed in media containing no FCS for 18

hours with 1.4 x 10
b

Cell Associated
Radioactivity
(cpm)

7

cpm/ml

Average of 2 determinations

1 2 5

I-BSA (O.Olmg/ml).
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that the cell associated radioactivity represents protein non-specifically bound to the surface of cells or
the culture dishes.
Similar results have been obtained in uptake
studies of labeled albumin macrophages by others (104).
Results obtained for uptake of other proteins in this
work are generally similar.
125

Uptake experiments were also performed with

I-BSA

before and after dialysis in order to verify that uptake
125

was not due to the accumulation of free

I by the cells

12 5

or the binding of free
results for the dialyzed
for

125

I to the culture plates.
125

The

I-BSA were similar to those

I-BSA before dialysis (Table 4) .

Blank plates, those with no cells added, treated in
the same manner as the plates with cells, took uo less
than 10% of the amount of label as did plates containing
cells, further indicating that the apparent accumulation
of radioactivity by the cells was not due to nonspecific
binding of label to the plates.
The.simultaneous addition of lysosomal protease in1 2 5

hibitors with the

I-BSA caused an increased overnight

accumulation of radioactive label (Table 5) .

This could

80

TABLE 4
12 5

1-BSA Uotake With Nondialyzed and Dialyzed

SamEle

% TCA Soluble

12 5

1-BSAa

lll/10 6 Cellsb

Nondialyzed

7.5

0.018c + 0.004

Dialyzed

0.3

0.016d + 0.001

-

aUptake was performed in media with 50% FCS for 16
hours.
bResults expressed as mean

± standard

cAverage of 5 determinations
d

Average of 4 determinations

deviation
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TABLE 5
125

I-BSA Uptake in the Presence of Inhibitorsa

Inhibitor

Inhibitor Concentration
in Media (mg/ml)

Volume of Media
in Cells
lll/10 6 Cells
0.013 + .006b

None

0.050 + .017b, c
.012b, d
0.073

Anti pain

0.29

Leupeptin

0.29

Pepstatin

0.06

0.040 + .OlOb, c
-

Chloroquine

0.05

0.060 + .014e

+-

aUptake was performed in media with 50% FCS for 18 hours.
b 3 Determ~nat~ons.
.
.

Mean + standard deviation

cDifference from control statistically significant,
p< .05.

duiffere~ce from control statistically significant,
p < . 01.

eAverage of two determinations

+- .;

L X

n -

2

1

.p < .1.
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be due to decreased degradation of the pinocytosed labeled protein by the cells.
The effect of alterations in protein structure on
the overnight accumulation of labeled BSA was also investigated.

Binding and nonbinding fractions of Affi-gel

blue purified BSA were found to be accumulated by macrophages at comparable rates (Table 6).
125

In contrast,

I-BSA denatured by boiling, which demonstrated a de-

creased binding to the Affi-gel blue column, showed an
increased accumulation uptake after an overnight incubation with cells.
The uptake of other iodinated proteins by macrophages following overnight incubation is shown in Table
7.

The value reported for ovalbumin was obtained both_

at ovalbumin concentrations of 1.1 ug/ml and 45 ug/ml,
The observation that the calculated volume of media is
indenendent of the concentration of label in the media is
evidence that uptake of this protein was also non-re.ceptor mediated.

The uptake of 13-galactosidase denatured by

freezing was less than that of the native form after an
overnight incubation with cells,

This is in contrast to

the results obtained with native and denatured BSA,

How

ever, it will subsequently be shown that the denatured
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TABLE 6

Effect of Protein Conformation on the Uptake of

125

I-BSA

a

Affi-Gel Blue Column Samples
Radioactivity in
Uptake Media 6
(cpm/ml x 10 )

Sample

Calculated Volume
of Media Taken Uo
~1/10 6 Cellsb ~

Before column

3.9

0.020 + .006c

Binding fraction

3.5

0.023d

Nonbinding fraction

3.5

0.018d

Boiled

12 5

I-BSA Samples

Sample

cpm/ml X 10 6
Uptake Media

Before boiling

6.3

0.018 + 0.002c

After boiling

1.5

0.087 + 0.012e

a
b

Uptake was performed in media with 50% FCS for 24 hours.
Values given as the mean + standard deviation

c

Average of 3 determinations
dVa 1ue represents a s~ng
. 1 e d·eterm~nat~on
~
.
e

Average of 5 determinations.

significant (p < .0005).

Difference statistically
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TABLE 7

Uptake of

12s

I-Labeled Proteins

a

Protein
Ribonuclease

0.043 + 0.015c

Arginase

0.034 + 0.015d

Enolase

0.078 (O.OS,O.lO)e

Ovalbtm1in

0.263 + 0.010 f

Catalase

0.049 + 0.016f

BSA

0.030 + 0.012g

Phosphorylase b

0.220 (0.340,0.100)e

B-Galactosidase

0.090 (0.091,0.089)e

Thyroglobulin

0.396 + O.llOf

aUptake was performed in media with 50% FCS for 18 to
24 hours.
bValues expressed as the mean + standard deviation
cAverage of 4 determinations
dAverage of 5 determinations
eAverage of 2 determinations.
parentheses
fAverage of 3 determinations
gAverage of 17 determinations

Individual values in
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form of S-galactosidase is degraded at a very much greater rate than the native form.
lated probably

re~resents

Since the amount accumu-

a steady state between uptake

and degradation, one would expect less of the denatured
form to accumulate.
D.

Release of Nondigestible Materials
The release of labeled dextran-sulfate into the

media from cultured macrophages was studied in order to
determine if nondigestible macromolecules could escape
from the cells and, if so, to quantitate the extent of
this release (Figure 8).

This experiment was performed

by counting both the cells and the media at various
times during the release.

It can be seen that there ap-

pears to be a rapid release of radioactivity within the
first 5 hours, followed by a very slow loss of label
from the cells (less than 0.5% per hour).

Approximately

20% of the label was lost in the initial phase.
results have been obtained in studies of the
release of

125

salts (105).

I-PVP and insoluble

128

Similar

u~take

and

Au labeled gold

This has been attributed to regurgitation

of the contents of some of the pinocytic and phagocytic
vesicles by the

ma~rophages

ment and/or cell death.

rather than to cell detach-

86

Figure 8.

Release of

14

C-activity from macrophages

that had pinocytosed 1 mg/ml dextran-sulfate
(32,000 cpm/ml) for 24 hours.

The samples were then

washed and fresh media added.

Uptake and release

media contained 30% FCS.

Each point represents a

single plate that was washed, the cells scraped off
the plates in 0.2 mls water, and Bray's solution
added to the cell suspension for scintillation
counting.
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E.

Degradation of Protein Substrates
The release of label from cells containing digest125

ible

I-labeled protein was also studied.

Figure 9

illustrates the time course of the appearance of radio1 2 5

activity in the media after uptake of
hours.

I-BSA for 15

As with dextran-sulfate, the release of TCA in-

soluble radioactivity is not linear.

Approximately 70%

of the released TCA insoluble radioactivity appears in
the initial rapid phase.

During the slow phase, less

than 0.1% per hour of the total label within the cell is
released as TCA insoluble radioactivity.

The similarity

between this result and that obtained with labeled dextran-sulfate suggests that the release of TCA insoluble
radioactivity represents regurgitation of intact protein.
The release of TCA soluble radioactivity also appears not
to be linear.

In this case, however, the release of TCA

soluble label continues well after the release of insoluble label has reached a plateau.

Similar results were

obtained with the other proteins studied.
One object of the experiments, whose results are
shown in Figure 9, is to measure the rate of degradation
of pinocytosed labeled proteins,

One method is to plot

the log of the percent of radioactively labeled protein

89

Figure 9.

12 5

!-activity in the media from
macrophages incubated with 1 x 10 7 cpm/ml
12 5

Release of

I-BSA in 50% FCS for 15 hours.

Media samples

(1% FCS) were removed from a single plate at various
time points and precipitated with an equal volume of
20% TCA - 1% phosphotungstic acid before counting.
The cells were counted at the end of the experiment.
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remaining in the cell vs time.

The percent cpm remain-

ing could be obtained with the help of the following
relationship:
%cpm
remaining

=

Total cpm taken up - cpm released
x 100
Total cpm taken up

However, if the percent cpm remaining is plotted vs time
it yields estimates for the rate of protein degradation
which are too large because this equation fails to account for label which is released through regurgitation
of intact or partially degraded protein.

Alternatively,

we could express percent cpm remaining as being equal to:
Total cpm taken up - TCA soluble cpm released

------------------------------------------------X
Total cpm taken up

100.

However, this underestimates rates of protein degradation
by overestimating the amount of label remaining in the
cell since the loss of TCA insoluble radioactivity
through regurgitation is not counted.

Clearly, therefore,

some method is needed to correct for the loss of TCA insoluble label from the cells with time.

An exact and rig-

orous correction is not possible because the mechanism by
which the TCA insoluble radioactivity is released is unknown.

92

As a first approximation we have assumed that the
TCA insoluble radioactivity released represents labeled
substrate which is regurgitated prior to any significant
exposure to the hydrolytic enzymes in the cell.

Accord-

ingly, we have subtracted the TCA insoluble radioactivity
released from the total radioactivity taken up by the
cell.

The amount of labeled protein taken up which is

available for degradation is then expressed as being
equal to the sum of the TCA soluble radioactivity released and the radioactivity remaining in the cell at the
end of the release experiment as shown below:
Total cpm available for hydrolysis

= Total TCA sol- + TCA cpm remaining at
uble cpm released

end of release
period

The percent radioactivity remaining in the cell at any
time, t, is thus given by:
~ cpm
~ngt

remain-

= Total

cpm - TCA soluble cpm releasedt
available

X
------------------------------------Total cpm available

100

Figure 10 illustrates the results in Figure 9 replotted
according to this equation (closed circles).

The open

circles show the same data uncorrected for the release
of TCA insoluble label.

In the latter case, the initial

rate of release of label (initial slope) appears more

93

Figure 10.

A replotting of Figure 9 using the equa-

tion (cpmt-cpmr) /cpmt

= % cpm

remaining at time t.

The log of this value is plotted versus the time in
hours.

The crosses represent the incorrected data

plotted in this fashion.

The squares show the same

data corrected for TCA insoluble label.
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rapid because of regurgitation of TCA insoluble label
from the cells.

However, the final rates of release

are more nearly similar for both curves since by 20
hours the rate of loss of label is due primarily to protein degradation in both cases.
In order to verify that the TCA insoluble radioactivity released by the cells into the media represented
larger molecular weight species, and that TCA precipitation was effective in removing these, media samples were
analyzed by Sephadex chromatography before and after precipitation with TCA.

Figure 11 shows the Sephadex G-50

elution profiles for the release media obtained on incu12 5

bating

I-BSA laden fibroblasts in unlabeled media for

24 hours.

Similar results were also obtained with re125

lease media from

I-BSA laden macrophages.

The elution

profile for the media prior to TCA precipitation shows the
presence of both large and small molecular weight species.
The small molecular weight peak was made up of at least 3
components.

This is in agreement with results obtained by

others (104, 126-128) which demonstrated the release of
labeled monoiodotyrosine, diiodotyrosine, glycyliodotyrosine and free

125

I from cells but no species of inter-

mediate molecular weight (300 to 10,000).

TCA precipita-

tion of the media removed the high molecular weight

96

Figure 11.

Chromatography of media (0), TCA sol-

uble media(+), and cell extracts (D) from a
125

I-BSA release experiment where fibroblasts were

allowed to take up label overnight.

Each 1.5 ml

fraction was counted directly in a gamma counter.
The Sephadex G50 column was eluted with 0.05M phosphate, 0.15 M NaCl, pH 7.3 at 24 ml/hour. The column
was previously calibrated and Vo corresponded to
fraction 12 while Vi was fraction 42.
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material.

Similar elution profiles were obtained for

media samples from macrophages fed

125

I-S-galactosidase

125

and

!-phosphorylase b.

In each case, the high molec-

ular weight component eluted in the void volume of the
column indicating a molecular weight greater than 30,000.
SDS electrophoresis of media yielded similar results;
only large and small iodinated molecular weight species
present in the release media.

In addition, the TCA in-

soluble material was shown to be of the same size as the
labeled protein before addition to the media.
125

The degradation and release of
cells fed

125

I activity by

I-BSA appeared to be nonlinear when plotted

on semilog paper (Figure 10) .

There are a number of

possible explanations for this behavior.

Some of these

are:
1)

The

125

I-BSA preparations used are heterogene-

ous, containing impurities which. are degraded
at rates which differ from that of authentic
125

2)

The

I-BSA.
12 5

I-BSA preparations contain denatured

forms of BSA which are
rates than native BSA.

deg~aded

at different

99
3)

The

12 5

I-BSA preparations are relatively

homogeneous, but the physical and chemical
environments of the individual labeled
amino acid residues in the protein are
heterogeneous.
4)

All the labeled amino acid residues in the
protein are equally susceptible to release
by cellular proteases but the cells themselves are heterogeneous with some having
a greater hydrolytic capacity than others.

5)

All the cells are homogeneous but each cell
contains a heterogeneous population of lysesomes, which remain segregated during the
release experiment, and which have different
levels of various hydrolases.

6)

The rate of release becomes progressively
slower with time because of progressive
changes which occur in the media during the
course of release.

7)

Some combination of the above explanations.

100
To distinguish between some of these possible exnlanations, release experiments were performed utilizing a
variety of labeled protein substrates, different batches
of macrophages, different cell types, and a different experimental procedure.

The results of these experiments,

which will be described below, tend to support explanation 3 for the biphasic appearance of the protein degradation curves.
To determine if the nonlinear curves for the release of label from

12s

I-BSA laden macrophages is due to

the presence of labeled impurities or denatured forms of
the protein, commercial preparations of

12

s

I-BSA were

purified by affinity chromatography on Affi-gel blue.
This gel binds albumin through an anion binding site on
the protein and denaturation of the protein would presumably lead to the destruction of this site.

Both the bind-

ing and non-binding fractions of these labeled BSA preparations yielded nonlinear release curves which were similar to each other and to those obtained with commercial
preparations before purification.
heat treated

12 5

Curves obtained with

I-BSA show some initial enhancement in

the rate of degradation of the pinocytosed protein substrate but are still remarkably similar to curves for

10:L
the native protein (Figure 12).

These results argue

against explanations 1 and 2.
To determine if the nonlinear curves were due to
the presence of heterogeneity in the population of macrophages used in these studies, the experiments were repeated with a number of different batches of stimulated
macrophages (thioglycolate media induced macrophages),
with activated macrophages (Freunds adjuvant induced
macrophages), and with baby hampster kidney fibroblasts.
All preparations of stimulated macrophages gave similar
time curves.

In addition, while it was observed that

activated macrophages, stimulated macrophages, and fibroblasts degraded albumin at slightly different rates, the
shapes of the curves were similar suggesting that the
curvature was a property of the protein and not the cell
preparations.

This conclusion was reinforced by results

obtained for the degradation of other protein substrates,
Figures 13 through 23 show the data obtained for protein
substrated.

The lines were generated by linear regression

of the data points.

In many cases, the early time points

appeared to fall above the line while the intermediate
time points appeared to be below the line.

In addition,

in almost all cases, the least squares line did not

102

125

Figure 12.

Release of TCA soluble

!-activity
6
from macrophages incubated with 6 x 10 cpm/ml
125

heat treated

I-BSA for 22 hours.

represents the mean

± standard

deviation.

least squares line is indicated.
coefficient= 0.977.

Each point
The

Correlation
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Figure 13.

Release of TCA soluble radioactivity from

macrophages incubated overnight with
The points indicate the mean

125

± standard

!-cytochrome c.
deviation for

6 experiments.

Cell preparations used were numbers 7,

8, 10, and 11.

The least squares line is indicated.

Correlation coefficient

=

0.838.
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Figure 14.

Release of TCA soluble radioactivity from

macrophages incubated overnight with
The points indicate the mean
3 experiments.
17, and 18.

12 5

!-ribonuclease.

! standard deviation for

Cell preparations used were numbers 12,

The least squares line is indicated.

relation coefficient

=

0.859.

Cor-
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Figure 15.

Release of TCA soluble radioactivity from

macrophages incubated overnight with
The points indicate the mean

12 5

± standard

!-hemoglobin.
deviation for

6 experiments.

Cell preparations used were numbers

9, 10, and 11.

The least squares line is indicated.

Correlation coefficient = 0.955.
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Figure 16.

Release of TCA soluble radioactivity from

macrophages incubated overnight with
The points indicate the mean
7 experiments.

~

125

!-arginase.

standard deviation for

Cell preparations used were numbers 7,

10, 11, 17, and 18.

The least squares line is indicated.

Correlation coefficient = 0.959.
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Figure 17.

Release of TCA soluble radioactivity from
l 2 5

macrophages incubated overnight with

I-enolase.

The

points indicate the average± variation for 2 experiments.
Cell preparations used were numbers 17 and 18.
squares line is indicated.

= 0.802.

The least

Correlation coefficient
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Figure 18.

Release of TCA soluble radioactivity from

macrophages incubated overnight with
The points indicate the mean
4 experiments.
10, and 11.

125

± standard

!-ovalbumin.
deviation for

Cell preparations used were numbers 5,

The least squares line is indicated.

relation coefficient

=

0.861.
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Figure 19.

Release of TCA soluble radioactivity from

macrophages incubated overnight with

12 5

!-catalase.

The points indicate the mean + standard deviation for
3 experiments.

Cell preparation used was number 13.

The least squares line is indicated.
coefficient = 0.958.

Correlation
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Figure 20.

Release of TCA soluble radioactivity from
125

macrophages incubated overnight with
points indicate the mean
experiments.

± standard

The

deviation for 23

Cell preparations used were numbers 1,

2, 6, 12, 14, 15, 16, 18, 19, and 20.
squares line is indicated.

= 0.937.

I-BSA.

The least

Correlation coefficient
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Figure 21.

Release of TCA soluble radioactivity from

macrophages incubated overnight with
b.

The points indicate the mean

for 4 experiments.
7 and 17.

125

± the

!-phosphorylase

standard deviation

Cell preparations used were numbers

The least squares line is indicated.

lation coefficient

= 0.872.
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Figure 22.

Release of TCA soluble radioactivity from

macrophages incubated overnight with
dase.

125

1-S-galactosi-

The points indicate the average ±variation for

2 samples.

Cell preparation used was number 13.

least squares line is indicated.
cient= 0.937.

The

Correlation coeffi-
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Figure 23.

Release of TCA soluble radioactivity from

macrophages incubated overnight with
bulin.

125

The points indicate the average

for 2 experiments.
12 and 18.

1-thyroglo-

± variability

Cell preparations used were numbers

The least squares line is indicated.

lation coefficient

=

0.985.
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extrapolate to zero on theY axis.

The results of the

linear regression calculations are shown in Table 8.
For each protein, the degradation rate constant, k
(hr- 1 ), was determined from the slope of the log plots
of cpm remaining vs time.

In an effort to judge the

contribution of the slower phase of the curves to the
total release of soluble label, least squares lines
drawn through later time points (> 8 hours) were extrapolated to time zero.

Table 8 also contains the per-

cent of total label released during the latter stage of
the degradation reactions for the proteins studied.
With the apparent exception of BSA, and thyroglobulin,
the proportion of label released at the slower rate
seems to increase with the increasing size of the protein.
If the fast and slow phases of the release curves
were due to the contributions of two distinct populations
of macrophages, one would have to postulate that the low
molecular weight protein substrate was preferentially
taken up by cells with a high hydrolytic activity, whereas high molecular weight substrates preferentially accumulated in cells with low levels of hydrolases.

No

obvious mechanism is known at present whereby this could

127
TABLE 8

Calculated Rate Constants and Y - Intercepts

Protein

Apparent First Ordera
Rate Constant (X 10 3 )

Y-Interceptb

Cytochrome c

28.3 + 2.8

-

.183 (83)

Ribonuclease

22.3 + 3.7

.333 (72)

Hemoglobin

33.5 + 1.5

Arginase

18.5 + 0.8

Enolase

14.3 + 2.7

Ovalbumin

12.6 + 1.6

Catalase

11.0 + 0.8

-

BSA

27.3 + 0.8

- .236 (79)

Phosphorylase b

11.0 + 1.2

13-Galactosidase

1.2 + 0.1

-

Thyroglobulin

17.5 + 0.9

.134 (87)
.136 (87)
.141 (87)
.185 (83)
.110 (90)

.029 (97)
.039 (96)
.135 (87)

aCa1culated from all data points.
+standard deviation.

Value given is mean
Units are h- 1 .

bCalculated from all data points after 8 hours.
The value in the parentheses is the percentage of label
released from the cells in the slower phase.
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occur.

These results obtained with different protein

substrates also tend to eliminate explanation 5 since
no mechanism has been reported which could account for
segregation of large and small pinocytosed proteins
into different populations of lysosomes.

Finally, the

following experiment was performed to determine if the
nonlinear protein degradation curves were due to accumulation of inhibitory metabolites in the media, as
macrophages are known to secrete inhibitors (159), or
depletion of some essential factor or nutrient from the
125

media.

Cells loaded with

I-BSA as described previous-

ly were allowed to release label as before, except at
each time point all the media was removed and replaced
with fresh media at 37° C.

The results obtained did not

differ significantly from those of previous experiments.
This experimental result also argued against the possibility that some of the TCA soluble radioactivity resulted
from the action of extracellular proteases on any intact
12 5

I-BSA present in the media.

In order to more defini-

tively eliminate this possibility, macrophages at a density of 4 x 10 6 cells added per plate were incubated for
12 hours in media.

At the end of this incubation, the

conditioned media was transferred to a cell free culture

1'29

plate and

12 5

I-BSA (10

6

cpm/ml) added.

There was no ob-

servable increase in the TCA soluble radioactivity even
after 18 hours of incubation at 37° C.
F.

Effect of Protein Size on Degradation Rate
The results of the protein degradation experiments

described in Figures 13 - 23 were performed with iodinated
protein substrates of varying molecular weight.

In gen-

eral, it was found that proteins with smaller subunit molecular weights were degraded more rapidly than those with
larger subunits.

This is shown graphically in Figure 24

where cpm remaining/cpm total at 35 hours is plotted
against the log (subunit molecular weight).
The data was analyzed by computer and linear regressions were calculated from all the data points.

There-

sults of those calculations are shown in Table 8.

For

each protein, the degradation rate constant, k (hr- 1), was
determined from the slope of the log plots of cpm remaining vs time (Figures 13 - 23).

In general, the rate con-

stant, k, decreases with increasing molecular weight.
results are shown graphically in Figure 25.
G.

Effect of Various Factors on Protein Degradation
The observation that the degradation of radio-la-

beled proteins by macrophages was reproducible and

The

130

Figure 24.

Plot of (cpmt-cpmr)/cpmt versus the

log of the subunit molecular weight of the protein.
a)

Least squares line for all data points
but BSA and Thyroglobulin.

Correlation

coefficient equals 0.952.
b)

Least squares line for all data points
but BSA, thyroglobulin, and B-Galactosidase.
0.962.

Correlation coefficient equals
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Figure 25.

Plot of the apparent first order rate con-

stant vs the log of the subunit molecular weight of
the protein.

Each point represents the mean + stan-

dard deviation.

The least squares line for all points

but BSA and thyroglobulin is indicated.
coefficient

= 0.928.

Correlation
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reflected the activity of a proteolytic enzyme system
within the cell prompted us to investigate additional
properties of this system.

In order to determine if the

rate of degradation of BSA was directly proportional to
its concentration in the cells, the specific activity of
12 5

the

!-labeled protein was decreased by adding varying

amounts of cold BSA to the uptake media,

As shown in

Table 9 there was no difference in the amount of label released by 30 hours when cells were previously exposed to
0, 0.1, or 1.0 mg/ml of cold BSA along with labeled BSA.
This was the result expected for a system in which the
rate of degradation of BSA is first order in substrate concentration.

In this range of BSA concentration, it was

not possible to saturate the degradative enzymes with unlabeled BSA.

In a related experiment, different amounts

of labeled BSA were added to the uptake media.

The
amounts were 0.2, 0.4, 0.6, 0.7, 1.2, and 1.5 x 10 7
cpm/ml.

In all cases, the amount of TCA soluble label

released with time was directly proportional to the amount
of label taken up by the cells (Table 10).
Cells were s,imultaneously loaded with dextran-sul125

fate (1 mg/ml) and

I-BSA to determine if the presence

135
TABLE 9

Release of Label From Cells With

12 5

I-BSA Endocytosed

in the Presence of Cold BSAa

Cold BSA Added
(mg/ml)

a

cpmt-cpmr at 30 Hours
cpmt

0

0.31,0.30

0.1

0.28,0.29

1.0

0.30,0.30

Uptake was performed in media with no FCS for 18 hours.

The

125

I-BSA was present in the media at 1 x 10

cpm/ml (O.OOSmg/ml).

7
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TABLE 10

Release of Label From Cells Incubated '.Jith Varying
Amounts of Labeled BSAa
cpm/ml x 10 6
12 5

I-BSA

a

cpmt
at 10 hours

2

0.48,0.60

4

0.54,0.62

6

0.50,0.62

7

0.48,0.62

12

0.51,0.57

15

0.56,0.58

Uptake was performed in media with 50% FCS for 19 hours.
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of dextran-sulfate in the uptake media could affect the
125

subsequent degradation of

I-BSA.

This experiment was

performed because we contemplated using dextran-sulfate
as a carrier for introducing proteinase inhibitors into
these cells.

As can be seen from Figure 26, dextran-sul-

fate can itself inhibit the release of TCA-soluble radioactivity when administered simultaneously with the substrate.

In contrast, when dextran-sulfate was added to

the release media after uptake of

12 5

I-BSA alone, it had

no effect on the rate of degradation of BSA.
The effect of varying the concentration of fetal
calf serum in the release media was also investigated.
In Figure 27 it can be seen that the release of TCA sol12 5

uble radioactivity from

I-BSA laden macrophages and

fibroblasts is inhibited in the presence of 50% FCS.

In

addition, the percentage of label regurgitated as TCA
insoluble radioactivity increases from about 25% to 50%.
To determine if these differences could be due to
changes in the precipitability of labeled products in the
presence of varying levels fetal calf serum,

1 25

I-BSA

laden fibroblasts were allowed to release label into

138

Figure 26.

Release of radioactivity from macrophages incubated overnight with 1 x 10 7 cpm/ml
125

I-BSA (*) and

( o ).
samples.

125

I-BSA plus dextran-sulfate

All values represent averages from 2
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Figure 27.

Release of TCA soluble radioactivity from

macrophages and fibroblasts incubated overnight with
1 x 10 7 cpm/ml

12 5

I-BSA in 50% FCS.

The labeled cells

were incubated in media with 1% FCS (+) or 50% FCS
( D ) and media samples removed at each time point

for analysis.

Each point is the average value from 2

duplicate plates.
a)
b)

Macrophages
Fibroblasts
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media containing 1% fetal calf serun.

Media samples were

removed at varying times and fetal calf serum was added
to half of each sample before precipitation with TCA.

The

addition of fetal calf serum had no effect on the amount
of TCA insoluble radioactivity present in each sample indicating that the increase in precipitable radioactivity
seen in release experiments in 50% fetal calf serum was
due to an increase in the amount of incomplete or nondigested protein regurgitated by the cells and not to an
increased precipitability of labeled protein in 50% fetal
calf serum.
H.

Effect of Protein Conformation on Protein Degradation
In order to determine the effect of denaturation

on the rate of degradation of pinocytosed proteins, prep12 5

arations of

I-BSA which had been boiled for 10 min-

utes were preincubated with macrophages and the rate of
release of TCA soluble radioactivity measured.

The dena-

turation of BSA by this method was verified by analyzing
the boiled
umn.

1 2 5

I-BSA with the Affi-gel blue affinity col-

The percent bound by the column decreased from 80%

to 30% after boiling.

Denatured BSA was degraded at a

rate only slightly faster than that of the native protein
(Figure 28).

This suggests that, for BSA, protein

143

Figure 28.

Release of TCA soluble activity from
macrophages incubated overnight in 1 x 10 7 cpm/ml
125
6
I-BSA (+) or 2 x 10 cpm/ml heat-treated
12 5

I-BSA ( o ) .

Each point represents the average

of 2 experiments for the heat-treated BSA and 7
experiments for the untreated BSA. The least squares
line for each is indicated.

144

''

-I.B

-a. a

''

''

''

.

''

t3

' ',
'

~1.1

•

. ,.s
.. 1.8+-----+----~_,----:!~----+~--- -1
-

~

I'S

HOURS

145

denaturation may not be the rate determining step in its
degradation in lysosomes.

During the course of our

studies, it was observed that solutions of a-galactosidase which had been frozen and thawed were degraded more
rapidly than samples not treated in this manner.
shown in Figure 29.

This is

This progressive increase in the

rate of degradation with successive cycles of freezing
and thawing was shown to be correlated with a loss in enzymatic activity (Table 11).

Clearly, for a-galactosi-

dase, a protein normally degraded slowly in macrophages,
denaturation produced a marked increase in its lysosomal
degradation rate.

This effect of freezing and thawing

on B-galactosidase was not observed with the other proteins studied when they were frozen and thawed.
I.

Relation Between Time of Uptake and Degradation Rate
If the nonlinear release curves are due to the

presence in protein substrates of peptide bonds with different susceptibilities to cleavage by proteinases, then
one would expect that partially degraded intermediate
species to accumulate in cells.

Since the release exper-

iments described in the previous sections were performed
after 18 hours of uptake of label, one would expect that

146

Figure 29,

Release of TCA soluble radioactivity

from cells incubated overnight in freshly labeled
12 5
12 5

I-S-galactosidase (+) and frozen and thawed
I-S-galactosidase ( o ) .

Each sample was run

in duplicate. The least squares line for ea,ch_ is
indicated.
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TABLE 11

Effect of Freezing on the Activity of S-Galactosidase
A/t

Sample

X

10- 4

a

% of Initial
Activity

15.2(15.4,14.9) b

Before freezing

5.9 + 0.3c

After freezing
a

38.8

Activity is expressed as the change in absorbance at

41 0nm per secon d times 10 -4.
(100

~1

of a 0.2

minutes with 300

~g/ml
~1

The S-galactosidase

solution) is preincubated for 5

mercaptoethanol (1 M) before the

addition of o-nitrophenyl, 6-D-galactopyranoside.
bAverage of 2 determinations.

Two values obtained in

parentheses.
c

Mean of 4 determinations + standard deviation.
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that these cells had accumulated quantities of polypeptide fragments more resistant to further degradation
having already released amino acids from the most susceptible regions of the molecule.

To confirm this hypoth125

esis, cells were allowed to accumulate
one hour.

I-BSA for just

The cells were then washed and incubated in 1%

fetal calf serum and the rate of release of TCA soluble
radioactivity measured.

With a one hour uptake, the ini-

tial rate of release of TCA soluble label into the media
is more rapid, and the nonlinearity of the logarithmic
plot is more apparent (Figure 30) .
both macrophages and fibroblasts.

This· was observed in
In contrast, the per-

centage of the label released in the TCA insoluble form
is the same after a one hour uptake as after the overnight
1 2 5

uptake.

The degradation of heat denatured

one hour uptake was also studied (Figure 31).

I-BSA after
Again, the

TCA soluble label released after a 1 hour uptake is initially more rapid and a greater percentage of label is
released in the rapid phase.
The effect of a one hour uptake on the rate of
release of TCA soluble label was studied utilizing the
protein substrates described previously (Figures 32 ~ 331:
It was found that phosphorylase b and thyroglobulin each
showed an increased rate of degradation and an increase

150

Figure 30.

Release of TCA soluble radioactivity from

macrophages incubated overnight (
with

125

I-BSA.

a )

or 1 hour (

a )

The 1 hour data is presented as the

mean+ standard deviation for 3 experiments.
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Figure 31.

Release of TCA soluble radioactivity from

macrophages incubated overnight ( • ) or 1 hour (
with heat-treated

l 2 5

I-BSA.

a )

The 1 hour data is pre-

sented as the mean+ standard deviation for 3 experiments.
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Figure 32.

Release of TCA soluble radioactivity from

macrophages incubated overnight ( • ) or 1 hour (

a )

12 5

with

!-phosphorylase b.

The 1 hour data is pre-

sented as the mean + standard deviation for 3 experiments.
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Figure 33.

Release of TCA soluble radioactivity from

macrophages incubated overnight (~ ) or 1 hour ( ~ )
with

125 !-thyroglobulin.

The 1 huur data is presented

as the mean+ standard deviation for 3 experiments.
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in the proportion of label released during the rapid
phase.

In contrast, the degradation rates of

ovalbumin were not much affected.

12 5

!-

However, in most

cases, the proportion of the total labeled protein released at the slower rate had been decreased.
Rate constants for the release of labeled uroteins
endocytosed for 1 hour were calculated as before.

The

results are shown in Table 12.
J.

Inhibitors
Finally, the effect of protease inhibitors on the
1 2 5

release of label from endocytosed

I-BSA was studied.

The inhibitors studied included leupeptin and antipain
for cathepsin B and pepstatin for Cathepsin D.

An al-

tered release of label was observed only when the inhibitors were added to the uptake media along with the labeled BSA for the overnight incubation.

There was· no ef-

fect observed when the inhibitor was added to the release
media only.

This result is understandable for pepstatin

since it is only taken up by pinocytosis (161} and does
not enter the cell quickly.

The explanation for this

result for leupeptin and antipain is not known since
these inhibitors are reported to be able to permeate the
plasma membranes of macrophages (22) .

TABLE 12
Calculated Rate Constants and Y-Intercepts For
1 Hour and Overnight Uptake Experiments
Apparent First Ordera
Rate Constant (X 10 3 )

Y-Interceptb

Protein

Overnight

1 Hour

Overnight

Ribonuclease

22.3 + 3.7

26.6 + 2.0

-

.333

- .558

Arginase

18.5 + 0.8

16.5 + 1. 3

- .136

- .216

Ovalbumin

12.6 + 1.6

7.8 + 0.6

.185

- .164

BSA

27.3 + 0.8

22.6 + 2.0

-

.236

-

.628

Phosphorylase b

11.0 + 1.2

28.6 + 1. 9

- .029

-

.454

Thyroglobulin

17.5 + 0.9

27.0 + 1.2

- .135

- .388

Denatured BSA

21.2 + 1.9

31.6 + 3. 7

- .430

- .972

aCalculated from all data points.
deviation.

1 Hour

Value given is mean + standard

bCalculated from all data points after 8 hours.
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Figure 34 illustrates the release of label in the
presence of the various inhibitors.

Pepstatin

(8.8 x 10-~) retarded the release of TCA soluble radioactivity from the macrophages.

Leupeptin (6.6 x 10-~)

and antipain (4.9 x 10-~) which inhibit lysosomal systeine proteinases, appeared to cause-an increased release
of label.

The percentage of label released in the ini-

tial rapid phase decreased with pepstatin and increased
with leupeptin and antipain.

The experiment was re-

peated using chloroquine (1 x 10-~). a lysosomotropic
agent, which is known to become concentrated within the
lysosomes where it disrupts intralysosomal pH and may
additionally inhibit cathepsin B and other lysosomal proteases.

It is also known to induce autophagy (143).

Chloroquine greatly inhibited the release of label into
the media.

Dextran-sulfate also inhibited the release of

label into the media (Figure 35) .

Its effects· on the

proteases papain, cathepsin B, and trypsin are shown in
Figure 36.
The effect of inhibitors on regurgitation of TCA
insoluble labeled protein into the media was also investigated (Table 13).

Leupeptin and pepstatin caused

a slight decrease in the percentage of TCA insoluble

161

Figure 34.

Release of TCA soluble radioactivity from
7
125
macrophages incubated with 1 x 10 cpm/ml
I-BSA
incubated in the presence of pepstatin, 60
chloroquine, 50

~g/ml

and antipain, 290

(0),

~g/ml

leupeptin, 290

(D).

~g/ml
~g/ml

(

~

<•),

All values from 3

experiments are given for the inhibitor studies. The
rate constants calculated for the degradation of
12 5

I-BSA in the presence of inhibitors are 0.047

(antipain), 0.036 (leupeptin), 0.011 (pepstatin),
0.006 (chloroquine).
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Figure 35.

Release of TCA soluble radioactivity from
macrophages incubated overnight with 1 x 10 7 cpm/ml
12 5

1-BSA alone (*) or in the presence of dextran

C 0 ) or dextran-sulfate ( a ) at 1 mg/ml.

The control

and dextran experiments were performed in duplicate.
The dextran-sulfate data represents the average of 4
samples.

Plotted is the% of total counts per minute

released during the initial rapid phase vs time.
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Figure 36.

The inhibition of papain(*), cathepsin

B (D), and trypsin (0) by dextran-sulfate.

The

concentration of dextran-sulfate is plotted against
the percent of the unhibited activity remaining at
that concentration.
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TABLE 13
Release of TCA Insoluble Radioactivity From Endocytosed
12 5

I-BSA in the Presence of Inhibitorsa.
Inhibitor Added

% Released as TCA
Insoluble

None

Leupeptin

27.6 + 3.8b
25.3 + 4.4c,d
- 3.0c,e
+
15.7 -

Pepstatin

14.3 + 3.0c,e

Chloroquine

36.5 (30.6,42.1) f

Anti pain

aRelease of Label was performed for 28 hours in media
containing 1% FCS.
bAverage of 4 determinations
c

Average of 3 determinations

dDifference from control not statistically significant
eDifferences from contro-l- statistically significant
(p<. 025)
£Average of 2 determinations.
Data not sufficient to determine statistical significance
of the difference from control values.
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radioactivity released while chloroquine caused a slight
increase.

Antipain had almost no effect.

These inhibitor experiments were also repeated with
cells which had been loaded with labeled protein and inhibitor for only 1 hour.
the release media.

Inhibitors were also present in

The results are shown in Figure 37.

Leupeptin and pepstatin now both appear to have little
effect.

Chloroquine, however, caused an inhibition of

the release of label.

169

Figure 37.

Release of TCA soluble radioactivity from
macrophages preincubated for 1 hour with 4 x 10 7 cpm/ml
125

I-BSA in the presence of pepstatin, 60

leupeptin, 290

~g/ml

~g/ml

(0), and chloroquine, 50

( 0),

~g/ml

The release with no inhibitors present is also shown
(+) .

From 2 experiments are given for the inhibitor

studies.

(

~
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CHAPTER IV
DISCUSSION
A.

Exoerimental Techniques
The uptake and digestion of extracellular proteins

by macrophages was studied by Ehrenreich and Cohn (104).
In their experiments, cells were maintained in glass
T-flasks after collection and protein uptake and degradation studies were performed in these flasks.

The general

procedure was as follows: Iodinated HSA, in a concentration of 10 6 -10 7 cpm/ml, was added to approximately
8 x 10 6 cells in medium 199 containing 50% newborn calf
serum.

After appropriate uptake times, cells were washed

with isotonic saline.

Cell associated radioactivity was

then collected by repeated freezing and thawing in distilled water.

Protein degradation studies were performed

by adding fresh media after the washing step and collecting all the cells in a flask for each time point in the
experiment.

They also collected the media at each time

point and measured TCA soluble and insoluble radioactivity
present.

They reported that the increase in the TCA solu-

ble radioactivity in the media with time was about equal:i.n
magnitude to the decrease in cell-associated radioactivity.
171

172

The amount of TCA insoluble label in the media showed no
consistent change and was attributed to intact protein
remaining from the pulse.

Because of the large quanti-

ties of cells required forT-flasks, we attempted to
adapt the methodology of Cohn and his associates to quantities of cells which could be grown on glass coverslips
immersed in media or on the bottom of small glass culture
dishes.

These efforts were unsuccessful.

In attempting

to locate the sources of error in the methodology, we
found that glass culture plates and coverslips were the
main causes of our difficulties.

It was observed that

iodinated proteins were nonspecifically adsorbed to glass
surfaces.

This radioactivity was firmly bound and was not

totally removed with subsequent washing.

However, on incu-

bating these surfaces with fresh media, the radioactivity
was slowly released.

Some of this labeled protein could

also be released by repeated freezing and thawing of the
plates.

This led to anomalously high estimates of the

amounts of labeled protein taken up by the cells, of the
amounts of labeled protein subsequently released by· the
cells, and of the amounts of cell-associated radioactivity remaining at the end of the release experiment,

These

173

errors were significantly reduced by performing all experiments in plastic culture dishes.

Also, it was found that

sonicating the plastic culture plates, in contrast to
repeated freezing and thawing, could release the cell associated radioactivity in preference to the non-specifically bound label.

Following sonication of the plates,

microscopic examination revealed very few if any attached
intact cells remaining.
Our method for measuring protein uptake and degradation, therefore, relied on the use of plastic multiplates with sonication to release the cell associated labeled protein.

Degradation studies were performed by col-

lecting aliquots from the media at various times during
the experiment and by collecting the cell associated radioactivity remaining at the end of the experiment.

To dis-

tinguish radioactivity arising from protein degradation
from the release of intact protein, each aliquot of media
was treated with TeA-phosphotungstic acid and the soluble
radioactivity measured.

With this techniaue, all the data

points in a single experiment could be obtained from a
single culture plate.

This resulted in improved preci-

sion because it was not necessary to apply uncertain
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corrections for differences in cell numbers between
plates.

Uncertainties arising from differences between

plates in the amounts of labeled protein taken up by the
cells were also avoided.

In addition, the sensitivity

was sufficiently great so that an entire experiment could
be done with 4 x 10 6 cells. This made it possible for
several experiments to be performed concurrently using
pooled cells from 4 to 8 animals.
The media samples collected were precipitated with
TeA-phosphotungstic acid and the soluble and insoluble
radioactivity determined for each time point.

In agree-

ment with Ehrenreich and Cohn, we found that the TCA-soluble counts increased with time.

However, in contrast to

their results, we also found a significant time dependent
release of TCA insoluble radioactivity.

This difference

may be due to the fact that the other workers were unable
to measure small changes in the level of TCA insoluble
radioactivity against a large background resulting from
the release of TCA insoluble labeled protein non-specif-.
ically adsorbed to their glass culture flasks,

In our

experiments, we were able to observe that the sum of the
TCA insoluble and soluble counts released equaled, within
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experimental error, the amount of label lost by the cells.
The reproducibility of this technique is demonstrated in Table 14.
tained for
B.
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This table summarizes the data ob-

I-BSA, our most thoroughly studied protein.

Uptake of Substrates
The uptake by cultured macrophages of the non14

digestible labeled polymer,

C-dextran-sulfate, was

found to increase with time with its concentration in the
medium.

We were able to calculate an endocytotic index

(EI) (105) which is defined as the volume of media in
order for them to have accumulated a measured amount of
radioactive material.

For a non-receptor mediated uptake,

the endocytotic index should be independent of the concentration of labeled polymer in the medium.

For recep-

tor mediated uptake, the endocytotic index should appear
to decrease with increasing concentration of the label.

In agreement with the literature (112), the endocytotic
index for dextran-sulfate was found to be greater than
that measured for dextran and was also observed to be
concentration independent.
Studies on the uptake of

12 5

I-BSA by cultured

macrophages appeared to indicate that the process was

Table 14
12 5

Cell Batch
Number

I-BSA Release Experiments

12 5

I-BSA
Batch
Number

(cpmt-cpmr) /cpmt
1 Hr

2 Hr

3 Hr

4 Hr

5 Hr

6 Hr

9 Hr

24 Hr

1

1

.963

.905

.875

.834

-

.740

.667

.341

1

1

.941

.907

.866

.837

-

.760

.. 676

.343

1

1

.967

.877

.855

.824

-

.703

.581

.229

1

1

.934

.873

.859

.790

-

.694

.633

.283

2

2

.972

.891

.895

-

.853

-

-

.552

2

2

.943

.856

.856

-

.728

-

-

.421

2

2

.970

.897

.900

-

.825

-

-

.496

2

2

.933

.908

.944

-

.841

-

-

.425

6

3

.962

.936

.920

.904

.840

.814

.721

.420
1-'
-...J
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Cell Batch
Number

I-BSA Release Experiments
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I-BSA
Batch
Number

(cpmt-cpmr) /cpmt
1 Hr

2 Hr

3 Hr

4 Hr

5 Hr

6 Hr

9 Hr

24 Hr

6

3

.972

.939

.902

.861

.835

.815

.708

.459

12

4

.974

.929

-

.856

-

.827

-

.467

14

4

-

.911

.936

.885

.838

-

.700

.483

15

4

.943

-

.934

.915

.848

-

.744

.356

15

4

.983

.937

.922

.902

.832

-

.828

.500

15

4

.961

-

-

-

.858

-

.779

.513

15

4

.966

.934

.919

.858

.845

-

.769

.465

15

4

.958

.949

.931

.899

.816

-

.700

.393

16

4

-

-

-

-

-

.830

.779
1-'
.........

.........

Table 14 (Cont'd.)
12 5

Cell Batch
Number

--

I-BSA Release Experiments

12 5

I-BSA
Batch
Number

(cpmt-cpmr) /cpmt
1 Hr

2 Hr

3 Hr

4 Hr

5 Hr

6 Hr

9 Hr

24 Hr

-

-

.848

.793

-

.727

.629

.447

.703

.604

.724

.590

.406
.399
.481

18

4

19

4

.912

.864

.804

.784

19

4

.922

.850

.810

.784

-

20

5

-

.910

-

-

.770

-

20

5

.820

-

.793

-

-

.933

-

Mean

.953

.904

.884

.848

.823

.758

.694

.423

Standard Deviation

.020

.030

.044

.047

.047

.054

.074

.079

t-'

.......
00
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not receptor mediated.
vation that

This was supported by the obser-

the uptake mechanism could not be saturated

with increasing concentrations of labeled BSA in the media
(Table 2) and by the observation that increasing amounts
of cold BSA did not inhibit the uptake of label (Table 3).
In both cases, the endocytic index measured after an overnight uptake was independent of BSA concentration.
The EI for BSA was less than those for the nondigestible substrates.

This could be due to ongoing pro-

tein degradation during uptake since the amount of label
accumulated by cells in a 24 hour period increases in the
presence of protease inhibitors.

The uptake of BSA was

also increased in the presence of dextran sulfate.

This

might have been due to the inhibition of degradation since
dextran sulfate was found to inhibit release of TCA soluble radioactivity (Figure 26).

It could also have been

due to an increase in pinocytosis by cells in the presence
of dextran sulfate (112} or to the formation of non ..
covalent dextran sulfate-protein conjugates which are
taken up by the cells (144) .
The uptake of BSA is also increas·ed following denaturation by boiling.

Similar results have been reported

for formalin-treated BSA with rat yolk-sac (107) .

This
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increased uptake is not due to decreased degradation in
the lysosomes as the rate of release of TCA soluble radioactivity from the denatured BSA was slightly greater than
that from native BSA (Figure 12).

Instead, it may have

been due to the exposure of hydrophobic regions of the
protein on denaturation with a concomitant increase in
non-specific adsorption to the plasma membrane of the
cells.

In contrast, a-galactosidase denatured by

freez~

ing and thawing had a decreased overnight uptake, hut
this was probably due to its much increased rate of degradation after denaturation (Figure 29).
C.

Release of Labeled Substrates
Cells loaded with non-digestible substrates were

found to release label in a rapid initial phase followed
by a very slow steady release which continued for at
least 24 hours (Figure 8).

This is in agreement with_·

studies previously reported (1051.
Cells loaded with labeled protein were found to
release both TCA insoluble and soluble radioactivity with
time (Figure 9) .

The time course of the release of TCA

insoluble label resembled that of the release of
14

C-dextran-sulfate by cells; there was a rapid initial

release followed by a slow continuous release of label.

1.81

This TCA insoluble label in the media was shown by gel
exclusion chromatography to be associated with a large
molecular weight fraction (Figure 11).

It has previously

been suggested that macrophages are capable of regurgitating the contents of some of the endocytic vesicles back
into the media (105) .

The amount of TCA insoluble label

released is greater when the release

~edia

FCS as compared with 1% FCS (Figure 27).

contains 50%
This could be

due to an increased membrane activity induced by fetal
calf serum (110, 111).
Because of this release of TCA insoluble label, all
media samples collected were precipitated 'tvith TCA s·o that
the counts due to TCA insoluble and soluble label could
be distinguished.

In order to assess the true rate of

lysosomal protein degradation, it was necessary to correct
for the release of intact labeled protein from the cells
as described in the results section.
The TCA soluble label released by cells preloaded
with

125

I-BSA was also analyzed by column chromatography

(Figure 11) and was found to be composed of low molecular
weight labeled products (MW > 300) in agreement with the
results of others (104, 126-129).

When data from the time

182
course of release of TCA soluble labeled products were
analyzed graphically for a first order reaction, the
experimental points did not appear to fall on a straight
line.

Thus, the rates of release of soluble products

during the late intervals in the reaction were slower
than expected on the basis of the data collected during
the early stages.

This was particularly apparent in

those experiments in which the cells had been pre-exposed to labeled substrates for only a short period
(1 hour).

Compare, for example, Figures 30 through 33.

Similar non-linear semi-log plots have been obtained when
native proteins are treated with proteinases in vitro,
and is probably due to a heterogeneity of the microenvironments in which the labeled amino acids residues reside
in the intact protein.

This causes the labeled residues

to be released from the protein at different rates.
Other possible explanations for the non . . . linearity
of the semi-log plots of the release data were also considered.

These include heterogeneity in the cell popula-

tions, heterogeneity in the lysosomal populations 1 and
heterogeneity in the substrates themselves.

If either the

first or second exnlanation
was correct 1 the findings
_,.
that the rate of release of label during the late stage, as
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well as the relative proportion of label released during
the early and late stages varied in a systematic way with
the size of the protein substrate would require mechanisms
for the selective uptake of large and small proteins into
different cell types or the selective sequestration of
large and small proteins into endocytic vesicles of different hydrolytic capacities.

~1hile

the possibilities can

not be excluded, the absence of any precedents for such
behavior together with difficulties in conceptualizing how
such mechanisms might work makes these possibilities seem
less likely.

The possibility that the substrates them-

selves are heterogeneous is not consistent with the finding that the shapes of the curves obtained with BSA were
similar between the various batches of BSA used, were only
slightly affected by heat denaturation, and could not be
eliminated by subsequent purification of the protein by
affinity chromatography.

Similarly, the apparent biphasic

degradation patterns observed with some of the smaller
protein substrates, which. exhibited a substantial fast
phase, would require a substantial heterogeneity which was
not observed when these proteins were subjected to either
agarose or polyacrylamide gel electrophoresis prior to
labeling.

In contrast, the apparent biphasic degradation
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patterns observed with large molecular weight proteins,
which characteristically exhibited a small initial rapid
phase, might have been due to the presence of low levels
of denatured protein or other protein contaminants.
A final possibility which must be considered is that
the method of labeling of protein results in a heterogeneous population of labeled protein.

This will be discus-

sed in greater detail in reference to differences in the
rates of degradation of large and small proteins.

For now

it is sufficient to say that no differences in the apparent degradation rates of protein were observed when they
were labeled by either the chloramine T method or the
lactoperoxidase method.

Moreover, even if the distribu-

tion of label within a protein were not the same for each
molecule, the non-linear semi-log plots still imply that
different labeled residues are released at different rates.
The existence of apparent biphasic degradation
curves for the various labeled proteins employed in these
experiments implies that cells can accumulate with time
labeled materials which are more resistant to subsequent
proteolysis than the original protein substrate.

Since

the period of uptake of the various labeled proteins
was usually about 24 hours, one might expect that these
labeled cells had accumulated significant amounts of
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resistant peptide fragments by the time the degradation
studies were initiated.

By decreasing the time of uptake

of labeled substrates to one hour, one might expect to
see a significant increase in the apparent rate of degradation and in the extent of the initial rapid phase.
In addition, this effect should be more exaggerated for
the large molecular weight proteins which had exhibited
the greatest differences in the rates and extents of the
fast and slow degradation phases.

A comparison of the

results in Figures 30, 32, and 33 show that these expectations were realized.
As a further test of the hypothesis that cells can
accumulate labeled polypeptide intermediates, the cell
associated radioactivity following a 20 hour uptake of
labeled BSA was subjected to gel exclusion chromatography.
The elution pattern was characteristic of a polydispersed
system containing high, intermediates, and low molecular
weight radioactive material (Figure 11).
The effect of protease inhibitors on the release of
TCA soluble radioactivity was studied.

Pepstatin, which

inhibits cathepsin D was added to the uptake media at a
concentration of 60

~g/ml

and was found to inhibit the

1 2 5

degradation of

I-BSA (Figure 34),

No e.ffect wa,s
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observed when pepstatin was added only to the release
media after the initial 20 hour uptake period.

Similar-

ly, pepstatin had no effect on degradation when added to
the uptake media when the duration of uptake was limited
to one hour.

These results are consistent with the con-

elusion that the uptake of pepstatin into cells is by
endocytosis rather than by passive diffusion,

Chloro-

quine, a lysosomotropic reagent which alters intralysosomal pH and which inhibits cathepsin B and other lysosomal
1 2 5

proteases (143), also inhibited the degradation of

I-

BSA which had been taken up by macrophages (Figure 34).
This inhibition occurred irrespective of whether chloroquine was added during the uptake period or during the
release period in agreement with earlier findings that
chloroquine can rapidly penetrate the cell by passive
diffusion (145).

In contrast to these results, leupep-

tin and antipain, inhibitors of cathepsin B1 and other
lysosomal thiol dependent proteases, actually enhanced
1 2 5

the apparent rate of degradation of

I-BSA,

However,

the concentrations of inhibitors used in these expriments
were high (290

~g/ml)

and part of their effect could be

due to other actions on the cells.

Since the olasma mem"

branes of some cells are permeable to these inhibitors it
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is not possible to rule out an extra lysosomal site of
action.

In addition, the presence of these inhibitors

in long-term culture of newborn heart cells has been
found to actually cause an increase in the level of
cathepsin B in these cells (151) .

As a consequence of

these considerations, the results we obtained with
leupeptin and antipain are difficult to interpret.
There is a substantial body of evidence in the literature which indicates that denatured proteins are degraded more rapidly by proteases in vitro than are native
proteins.

This may be due to an increase in the accessi-

bility of previously buried peptide bonds in the denatured state or to an increased conformational flexibility
of the peptide backbone in the denatured state,

Intui-

tively, therefore, one might expect denaturation to have
a greater effect on the degradation rates of large proteins, since these contain a greater proportion of buried
peptide bonds and are degraded more slowly in the native
state in vivo.

A comparison of the degradation rates for

native and denatured BSA and B-galactosidase in Figures 28
and 29 confirm this expectation.

Thus, while the dena-

tured protein was degraded more rapidly than the native
protein in both cases, the effects of denaturation were
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much greater for the larger S-galactosidase than for BSA.
One complication in interpreting the results of
such denaturation studies is that we have no assurance
that the denatured states of these two proteins in dilute
aqueous solution are in any way equivalent, since our
definition of denaturation is simply a loss of biological
activity.

For BSA, the absence of biological activity

was judged by the failure of the heat treated protein to
bind the ligand conjugated to agarose in the affi-gel blue
column.

For B-galactosidase, denaturation was judged by

the loss of enzymic activity following repeated freezing
and thawing of dilute aqueous solutions of the enzyme.
D.

Protein Structure and Degradation Rate
There appeared to be a relationship between the

subunit molecular weights and the degradation rate.s of
the various protein substrates. studied (figure 24).

We ·

have previously suggested that th.e non-linear semilogarithmic plots of our degradation data were due to differences in the susceptibilities of various pepti.de bonds
to proteolytic cleavage.

Moreover, the increase in the

rate of degradation of denatured B-galactosidas:e may have
been due to an increased exposure of normally buried peptide bonds in the denatured state,

This leads to th.e
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idea that the degradation rates of various proteins should
in some way be related to the fraction of the total number
of peptide bonds exposed to solvent and thus accessible
action of the lysosomal proteases.

Since the surface area

of a sphere varies with the square of its radius while its
volume varies with the cube of its radius, the ratio of
surface area to volume should be inversely proportional to
its radius (A/V

~

1 K).

Therefore, for a series of glob-

ular proteins which approximate spheres, one would expect
that the fraction of peptide bonds accessible to proteases,
and thus the apparent degradation rate might

b~ propor~

tional to the inverse of the subunit radius.

Figure 38

shows a plot of 1/relative subunit radius vs tne log of
the fraction of undigested labeled material remaining in
the cell after 35 hours for the various proteins in this
study.

In this plot, r was calculated by assuming that

all the proteins or protein subunits were spheres of equal
density.
A relative r was then calculated by setting r for
cytochrome c equal to 1.

As can be seen, a straight line

can be drawn through most of the data points.

Two pro-

teins whose degradation rates deviate markedly from this
line are thyroglobulin and BSA.

In each case, both pro-

teins behave as if their subunit molecular weights were
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Figure 38.

Plot of 1/relative radius versus the

log of (cpmt-cpmr) /cpmt at 35 hours.

Solid line,

all the proteins except thyroglobulin, BSA and
a-galactosidase; dashed line, all the proteins
except thyroglobulin and BSA.
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much smaller than expected.

The anomalous behavior of

thyroglobulin can be readily explained in terms of its
structure and biological function.

Characterization of

thyroglobulin synthesized from thyroglobulin messenger
RNA suggests that it is composed of two polypeptide
chains of two polypeptide chains of 300,000 to 330,000
molecular weight (146, 147).

This protein appears to be

highly susceptible to limited proteolysis so that when the
isolated 660,000 molecular weight dimer is subjected to
SDS disc gel electrophoresis in the presence of mercaptoethanol, a variety of discrete bands are obtained
with a range of molecular weights from 19,000 to 330,000
(148).

It has been suggested that the monomer consists of

a linear array of a repeating peptide unit of molecular
weight of approximately 19,000 (148, 149).

On this basis,

it would be expected that the thyroglobulin subunit could
behave in our system as if it were much smaller than
330,000.

From our data, thyroglobulin appears to be com-

posed of subunits of average molecular weight of 32,000.
The explanation for the anomalous behavior of BSA may be
similar.

Recent studies have shotvn that this orotein is

rapidly cleaved by endopeptidases into smaller fragments
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which retain important structural and functional features
of the intact protein (150) .

BSA thus behaves as if it

were composed of several globular domains linked by short
peptide segments.

In our system, such a molecule might be

expected to behave as if it were composed of smaller subunits.

From our results, BSA appears to have an average

subunit molecular weight of 17,000.
E.

Comparisons With Intracellular Protein Degradation
The work by many authors cited in this dissertation

indicate the possible existence of more than one pathway
for intracellular protein degradation.

One pathway ap-

pears to involve lysosomes and is sensitive to inhibition
by lysosomal proteinase inhibitors and agents which. disrupt lysosomal function.

The second may involve an extra-

lysosomal degradative system.

However, this conclus·ion is

still controversial and others have proposed tha.t the lysosome is the major s·ite of cellular protein turnover.

The

work described in this dissertation was undertaken with
the belief that the results might permit these two alternatives to be distinguished,
Table 15 sunnnarizes some of the characteristics of
intracellular protein turnover which must be explained by
any description of this process.

Figures 1 and 3 describe
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the two types of alternative mechanisms which have been
proposed.

The model described in Figure 1 assumes· that

cellular proteins are degraded primarily in lysosomes
with the proteolytic steps being rate determining.

Thus,

the half life of a cellular protein is proported to be
related to its inherent susceptibility to the cocbined
action of the various proteolytic and peptidolytic activ ..
ities in the lysosome.

In order to account for differ-

ences in turnover rates between proteins, this model fur ..
ther assumes that the transfer of proteins between the
lysosome and other cellular compartments can occur in two
directions.

Thus, stable proteins are those which. escape

the lysosome before significant degradation can occur,
while short lived proteins are those which are. almost
completely degraded wi.thin the period of their residency
in the lysosome.

Although no compelling evidence has

ever been presented to s·upport a two way transfer of proteins into the lysosome, it has been noted that lysos:omes
themselves turn over, and it is conceivable that at s.ome
point near the end of their lifetime they become "leaky.''
This model predicts that the properties of intracellular
protein turnover should strongly resemble thos.e of lys.osomal protein degradation,
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A second form of model 1 proposes that the rate
determining step in cellular protein turnover is the
transfer of the substrate into the lysosome.

Accordingly,

a steady state should exist in which the amounts of various cellular protein substrates within the lysosome are
related to the ratios of their rates of transfer into the
lysosome and their rates of degradation within the lysosome.

This model proposes that differences in turnover

rates between proteins are largely due to differences in
their rates of sequestration by lysosomes.

Thi_s model,

makes the following predictions: Increased protein turnover caused by nutritional deprivation re.sults from an
increased rate of transfer of protein into the lysosome
and is reflected in an increased size of the lysosomal
substrate pool; low concentrations of lysosomal proteinase
inhibitors should produce only a transient inhibition
which diminishes as the substrate pool within the lysosome
increases to a new steady state level; intermediate levels of inhibitors should produce a more persistent inhibition, while high concentrations should block protein turnover and produce an extensive vacuolization of the cell.
In agreement, it has been observed that the size and protein content of lysosomes is initially low in the fed state
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in perfused rat liver, but increases in proportion to
increases in protein turnover during amino acid deprivation (157, 158).

In addition, the inhibition of pro-

tein degradation in cultured macrophages induced by
chloroquine is accompanied by a profound increase in the
number and size of vacuoles within the cell (88).

The

failure of lysosomal proteinase inhibitors to completely
block cellular protein turnover may not be incompatible
with models 1 and 2, because the large number of proteolytic and peptidolytic activities within the lysosome
may preclude the complete inhibition of this system by
one or a few agents.

A more serious objection may be the

apparent lack of additivity of these inhibitions (72).
The third model, described in Figure 3, proposes
the existence of at least two pathways of cellular protein degradation.

One pathway associated with lysosomes

degrades most cellular proteins at a comparable rate
which may depend on how rapidly portions of the cytoplasm
are sequestered in lysosomes.

The second pathway is

extralysosomal and degrades various cellular proteins at
different rates depending on their accessibility, their
inherent susceptibility toward proteolysis, or the ease
with which they undergo spontaneous physical or chemical
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modification to a more susceptible form.

Accordingly,

long live proteins are relatively resistant to the action
of this system and are degraded primarily in lysosomes,
short lived proteins are sensitive to the action of the
extralysosomal system and are degraded by it.

Proteins

with intermediate half-lives are degraded in varying proportions by both systems.

This model can account for dif-

ferences in degradation rates between proteins, for the
inability of inhibitors to completely block protein turnover (Table 15), for differences in the sensitivity of
short-lived and long-lived proteins to inhibition of degradation (Table 15), and for the observation that starvation, which increases the contribution of the lysosomal
pathway, ameliorates the differences seen in the degradation rates between proteins.
The work described in this dissertation allow a distinction to be made between some of the models described
above.

Thus, I have observed that small proteins are de-

graded more rapidly in the lysosome than are large proteins despite the fact that small proteins turnover more
slowly in vivo (Table 15).

Similarly, I have observed no

important differen-ces in the rate of degradation of acidic
and basic proteins despite the fact that acidic proteins

TABLE 15
Comparison of Intracellular and Extracellular Protein Degradation8
Physical Properties of Proteinsb
Intracellular Proteins
Long Half-Life
Short Half-Life

Extracellular Proteins
Long Half-Life
Short Half-Life

Low Molecular
Weight
Basic pi
Normal Conformation or Amino
Acid Composition

Low Molecular Weight
High Molecular
Weight
Normal Conformation
No Relationship
Seen Between pi
and Degradation
Rate
Normal Conformation

High Molecular
Weight
Acidic pi
Abnormal
Conformation
or Amino Acid
Composition

Effect~ of Inhibitors on Protein Degradationc

·Intracellular Proteins
Inhibitor
Ftital Calf
Serum
Pepstatin
Antipain

Long. Half-Life
Inhibits 10%
(10%)
Inhibits 0-40%
(10-100 }.lg/ml)
Inhibits 18-28%
(50 }.lg/ml)

Short Half-Life
No Effect
(10%)
No Effect
(50 }.lg/ml)
No Effect
(50 JJg/ml)

Extracellular Proteins
Inhibits 29%
(50%)
Inhibits 59%
(60 }.lg/ml)
Increases 74%
(290 }.lg/ml)

~

\0

00

TABLE 15 (Cont'd.)

Effects of Inhibitors on Protein Degradationc

Intracellular Proteins
Inhibitor

Long Half-Life

Short Half-Life

Leupeptin

Inhibits 20-70%
(10-50 1Jg/ml)
Inhibits 20-70%
(10-50 1-1g/ml)

No Effect
(10 lJg/ml)
Inhibits
12-45%
(10-50 1Jg/ml)

Chloroquine

a

Extracellular Proteins

Increases 33%
(290 lJg/ml)
Inhibits 78%
(50 1-1g/ml)

The values for extracellular protein represent the values for our data
at 24 hours degradation time.

b

References 17 - 33, 152.

c

References 22, 46, 68, 72, 73, 77, 85, 90, and 151.
.......
1.0
1.0
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appear to turnover more rapidly in vivo than do basic proteins (Table 15).

However, our samples were too limited

to fully test the effect of pi on degradation rate.

These

observations indicate that the rate determining step in
protein turnover is not proteolysis in the lysosome, arguing against model 1.

My results also suggest that the

rate of lysosomal protein degradation is more sensitive to
the effects of chloroquine and pepstatin than is the overall rate of turnover of cellular protein.

The inhibitions

by these reagents, which I have observed, more closely
resemble those seen for the degradation of long-lived proteins, and are clearly much greater than those observed
for short-lived proteins (Table 15), supporting model 3.
F. Summary
This study characterized the processes of uptake and
degradation of extracellular proteins by cultured macrophages and fibroblasts.

It was found that labeled BSA was

taken up by the macrophages at a rate that was proportional
to its concentration in the medium and was independent of
the amount of unlabeled BSA present.

This result suggests

that BSA uptake was either not receptor mediated or that
it was not possible to saturate the receptors under the
experimental conditions used.
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Cells loaded with labeled proteins released TCA
insoluble and soluble radioactivity into the medium.

The

appearance of TCA insoluble label may have been due to
regurgitation of undegraded protein and its release was
virtually complete by 6 hours.

TCA soluble labeled prod-

ucts were released during the entire course of the experiment and was due to degradation of the labeled protein
within the cells.
The initial rate of r'elease of the TCA soluble
label was proportional to the amount of label taken up
by the cells and therefore appeared to be first order in
substrate.

However, first order plots of the releas-e data

were non-linear over time.

This was interpreted to mean

that labeled amino acid residues in different regions of
the protein were cleaved at different rates.

It was fur-

ther hypothesized that the slower degradation observed
at later times was due to the accumulation of protein
fragments more resistant to cleavage than the intact protein.

In confirmation of this conclusion. it was- observed

that short uptake periods resulted in increased rates of
release of soluble degradation products.
The release of TCA soluble label was inhibited by
50% FCS, chloroquine, and pepstatin.

This inhibition is
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consistent with degradation having occurred in the lysosome.
The overall rate of degradation of a protein was
inversely proportional to its subunit size.

This obser-

vation can be explained if it is assumed that the degradation rate of protein is proportional to the fraction of
its peptide bonds exposed on the surface.

For a spheri-

cal protein, this fraction should be inversely proportional to its molecular radius.

In confirmation, it was·

shown that prior denaturation produced a greater increase
in the degradation rate of a large protein than of a
small protein.
Finally, a comparison of our results with. those obtained for cellular protein degradation argues against a
model for the latter in which the rate determining step is·
proteolysis in the lysosome.

Instead, a model involving

both lysosomal and extra-lysosomal degradative sys;tems in
cellular protein turnover is favored,
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